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ABSTRACT 
 
MICRONUTRIENT STATUS AND TELOMERE LENGTH IN ADULT MEN 
AND WOMEN 
 
SEPTEMBER 2018 
 
CHRISTY S. MAXWELL, B.S., UNIVERSITY OF MICHIGAN-FLINT 
 
Ph.D. UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor Elena T. Carbone 
 
 
Background: Telomeres are the noncoding nucleotide sequences at the end of eukaryotic 
chromosomes, serving to protect DNA during mitotic division. Given their guanine-rich 
structure, telomeres are highly susceptible to oxidative damage often mediated by 
inflammation. Recently, telomere attrition and dysfunction have been associated with 
age-related diseases, including cardiovascular disease, type 2 diabetes, Alzheimer’s 
disease, and certain cancers. Several modifiable risk factors have also been associated 
with shortened telomere length, including physical inactivity, obesity, stress, smoking, 
and poor diet.   
Objective: We examined the relations between vitamin B12 status, folate status, and iron 
status, relative to telomere length in eligible participants in the 1999-2002 US National 
Health and Nutrition Examination Survey.  
Design: Eligible participants had no evidence of kidney or liver disease, or pregnancy, 
and had complete data on outcome, exposure and covariates (n = 5,941). Low B12 status 
was defined as serum B12 ≤148 pmol/L or serum methylmalonic acid concentration ≥210 
nmol/L. Folate status was defined as serum folate ≤13.4 nmol/L (suboptimal), and ≥45.3 
nmol/L (elevated). Iron (Fe) status was defined as meeting ≥2 of the following criteria: 
serum ferritin ≤15 µg/L, erythrocyte protoporphyrin >80 µg/dL, transferrin saturation 
(TS)<20%, hemoglobin <12 (women) or <13 (men). Elevated Fe was defined as 
TS>50%, serum Fe ≥155 µg/L (women) or ≥160 µg/L (men), or serum ferritin ≥150 µg/L 
(women) or ≥200 µg/L (men) with no signs of inflammation.  
Results: After controlling for covariates including, age, race/ethnicity, sex, BMI, 
education level, smoking, alcohol intake, and blood glucose level, low B12 status in the 
presence of elevated folate status was significantly associated with a shorter mean 
telomere length in middle-aged adults. Elevated iron status was associated with a shorter 
mean telomere length in adult men and women. 
Conclusion: In middle-aged adults, low vitamin B12 in the presence of elevated folate 
status was associated with significant telomeric attrition equivalent to 27 years of 
additional biological aging. The shorter mean telomere length associated with an elevated 
iron status was equivalent to 2.6 years of additional biological aging in adult men and 
women. Thus, poor micronutrient status is associated with shorter mean telomere lengths 
in adult men and women.   
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CHAPTER 1 
REVIEW OF TELOMERES 
A. Background 
 
Telomeres are repetitive, non-coding nucleotide sequences at the end of all 
vertebrate chromosomes (TTAGGG in humans). They function as protective caps and 
play an indispensable role in chromosome replication and stability (McClintock, 1941). 
The guanine-rich 3’ projection is thought to be of particular importance; acting as a 
buffer to protect gene coding sequences enabling gene continuity through DNA 
replication. The theory of a “buffering” segment of DNA was first reported by Olovnikov 
in 1973, where he properly ventured that with each round of cell division, a portion of 
this segment (telomere) would be lost, without interruption to DNA function. 
Furthermore, he stated that the length of each telomere would be important in 
determining the cell’s ability to proliferate (Montpetit et al., 2014).  
Telomeres have been accepted as essential components in cellular biology with 
the 2009 Nobel Prize in Physiology or Medicine going to Elizabeth Blackburn, Carol 
Greider, and Jack Szostak for their discovery of how chromosomes are protected by 
telomeres and the enzyme telomerase. Due to its linear formation, eukaryotic 
chromosomal DNA requires both the established DNA polymerase as well as the RNA 
enzyme telomerase to complete the replication process (Blackburn, 1991).      
 Oxidative stress mediated by reactive oxygen species (ROS) is responsible for 
single strand breaks in DNA where the telomeric GGG (guanine) end is highly 
susceptible to damage (Matthews et al., 2006; Von Zglinicki, 2002). This susceptibility, 
coupled with the knowledge that telomeric DNA has a reduced ability for repair, is 
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suggestive of accelerated loss and cell death under such ROS stressors.  With each round 
of mitosis, telomeric DNA naturally shortens, resulting in cell senescence once a critical 
degree of telomere attrition has been reached (Blackburn, 1991). In cell culture, acute 
DNA damage induces premature “replicative senescence” mediated by accelerated 
attrition of telomeres (Matthews et al., 2006; Von Zglinicki, 2002).  
Telomere attrition is now a widely accepted cellular event associated with natural 
aging. Moreover, telomere attrition and dysfunction have been shown to be causal factors 
in many age-related diseases.  Thus, telomere length assessment embraces potential as a 
biomarker of risk assessment for numerous diverse health outcomes. There are many 
methods used in determining telomere length, all with advantages and disadvantages 
depending upon the specific study parameters.  
1. Telomere Assessment 
  Several assessment methods may be utilized in determining telomere length. The 
following briefly describes the primary methods, along with their strengths and 
weaknesses.  
a. Terminal Restriction Fragmentation  
 Southern Blot analysis of terminal restriction fragments (TRF) is the original 
method developed for determining telomere length, and thus is often referred to as the 
“gold standard” method. Here, genomic DNA is enzymatically digested in a manner that 
preserves the telomeric DNA. Intact telomeres from all chromosomes are resolved using 
gel electrophoresis, with fragments identified via Southern Blot analysis. Varying lengths 
will present as a smear, with size being compared to a DNA standard (Montpetit et al., 
2014).   
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 Strengths of the TRF method include the ability to compare the results to other 
investigator’s data, as well as, providing a kilobase size estimate for the telomere length. 
Limitations include the possible overestimation in the true telomere length due to non-
specificity of the enzymatic process. The DNA must be of high-quality and not degraded, 
thus collection and storage techniques must be carefully monitored. Results can vary 
between labs depending upon the restriction enzymes used.  In addition, TRF requires 
large amounts of DNA (mg) per sample, which may prohibit its use in large-scaled 
studies (Montpetit et al., 2014).  
 b. Polymerase Chain Reaction-Based Techniques 
 The initial qPCR technique was developed by Cawthon et al. in 2002 and is used 
most frequently by researchers. Telomere length was quantified by comparing the amount 
of telomere amplification product (T) to a single-copy gene (S), both performed in 
separate tubes (Cawthon, 2002). The T/S ratio was calculated to yield a value that 
correlates with the average telomere length. Favorably, this technique requires minimal 
amounts of DNA (ng), is performed for a reasonable cost, and is amenable to high-output 
testing, making it well suited for large epidemiological studies. A shortcoming however, 
involves the possibility of intra-operator pipetting errors; thus, variations in the amount of 
DNA present in the “T” and “S” tubes could compromise the precision of the assay. In 
addition, the qPCR method results in variations, which limits the ability to allow for 
comparisons between studies (Montpetit et al., 2014).  
c. Single Telomere Length Analysis (STELA) 
 The STELA method is a qPCR-based method that was developed to detect the 
length of specific, individual telomeres. While the first two methods discussed provide an 
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average telomere length, this method provides the means for recognizing the presence of 
short telomeres on a single chromosome. This method is useful in studies investigating 
the presence of critically short telomeres of specific cells in low concentrations. 
Limitations include the inability to identify long telomere lengths, as well as its labor-
intensive, technically challenging protocol (Montpetit et al., 2014).  
d. Quantitative Fluorescence in situ Hybridization (Q-FISH) Methods 
 Q-FISH methods involves assessing metaphase chromosomes (or interphase 
nuclei) following a fluorescence labeling. In contrast to the TRF and qPCR methods, Q-
FISH utilizes cells as the substrate, rather than DNA. In general, Q-FISH assays have the 
advantage of estimating sizes for each of the individual 92 telomeres in humans (and not 
limited to an average or short lengths). These assays have been essential in providing 
information about variation in length of telomeres between different chromosomes and is 
particularly valuable in measuring telomere length in rare cells. However, the metaphase 
Q-FISH approach is labor intensive, expensive, and difficult to perform, making it 
impractical for large-scale epidemiology studies.  An adapted version of this Q-FISH 
method is called flow-FISH, which has the capability of sorting cells into subpopulations 
based on size, granulation, and/or antibody labeling. Flow-FISH was the first assay to be 
used clinically in diagnosing individuals with dyskeratosis congenital – a condition 
associated with shortened telomere lengths (Montpetit et al., 2014).  
 Further Q-FISH approaches, as well as other methods including the hybridization 
protection assay (HPA) and single-strand 3’ overhang measurement methods are also 
available. As with the methods described above, each have strengths and weaknesses 
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associated with measuring telomere length, but are utilized much less frequently in 
epidemiological studies (Montpetit et al., 2014).   
2. Non-Modifiable Determinants of Telomere Length 
a. Sex and Telomere Length  
 Aging is a non-modifiable factor that inevitably results in telomeric attrition. Sex 
and race are two other factors that are genetically predetermined and may influence 
telomere length. Gardner et al. (2014) conducted a systematic review and meta-analysis 
on sex and telomere length. Some studies have found longer leukocyte telomeres in 
women than in men, while others have found no association, or even the reverse. 
Theories as to why women may have longer telomeres include the role of estrogen. 
Telomerase contains an estrogen-responsive element that is thought to stimulate 
telomerase activity (Mayer et al., 2006). Additionally, telomeres are highly sensitive to 
oxidative stress and women produce less reactive oxygen species (ROS) than men 
(Nawrot, Staessen, Gardner, & Aviv, 2004). It has also thought that the antioxidant 
properties of estrogen may allow women to metabolize ROS more efficiently, thus 
protecting the susceptible telomeric strands.  
 From a potential 10,149 studies, Gardner et al. included 40 datasets in the meta-
analysis. Telomere length was determined by Southern Blot (17 datasets), qPCR (19 
datasets) or Flow-FISH (four datasets) in the eligible studies. There was little evidence 
that the association between sex and telomere length varied by age group, but it did vary 
by measurement method. The summary estimates of effect showed longer telomeres in 
females than in males only in the Southern Blot method. The investigators concluded that 
the failure of the qPCR and Flow-FISH methods in finding longer telomere lengths in 
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females compared to males was due to higher experimental variability in the techniques 
(Gardner et al., 2014).  
b. Race/Ethnicity and Telomere Length  
Racial disparities have been associated with lower life expectancy, higher rate of 
disability, and earlier onset of chronic disease (Murray et al., 2006; Rewak et al., 2014). 
One theory as to these disparities is the “weathering” hypothesis that Geronimus et al. 
(1992) first suggested. This theory explaining such disparities, suggests that differences 
found in populations in the early stages of chronic disease, result from different life 
experiences, stress exposures, and access to coping resources associated with social 
identities or “assignments” such as race/ethnicity, from conception through adulthood. 
Nonetheless, data on race/ethnicity and telomere length have differed. Several studies 
have found longer telomere lengths in black compared to white participants (Adler et al., 
2013; Aviv et al., 2008; Hunt et al., 2008; Needham et al., 2013).  In contrast, Geronimus 
argued these findings were the result of highly selected samples that included few to no 
social covariates (Geronimus et al., 2015). In this study, Geronimus et al. investigated the 
relationship between race-ethnicity, poverty, and urban stressors and telomere length in a 
community-based study in Detroit, Michigan. In a sample of 202 black, white, and 
Mexican adults taken from three Detroit neighborhoods, the investigators measured 
telomere length and self-reported survey data including information on SES, 
psychosocial, neighborhood, and behavioral stressors. The investigators found that after 
stratifying each racial/ethnic group on a poverty-to-income ratio (PIR), black participants 
had shorter mean telomere length compared to nonpoor white participants. However, this 
finding was not significant. The authors found that all racial/ethnic groups were sensitive 
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to the addition of socioeconomic, psychosocial, coping, and biobehavioral variables when 
added to the model.  
Interestingly, the authors also found that poorer whites had significantly shorter 
telomere lengths than non-poor whites (p<0.01); whereas this relationship with poverty 
was not observed among the black or Mexican participants. The authors cite that whites 
may be more sensitive to their perceived socioeconomic failures when the expectations of 
white privilege and the current circumstances are not congruent (Geronimus et al., 2015). 
Thus, great care in study design and analyses should be taken when investigating future 
relationships on telomere length among different race/ethnicities.  
3. Modifiable Determinants of Telomere Length 
a. Overview 
Telomere length is genetically determined  (Vasa-Nicotera et al., 2008); however, 
telomere attrition has been associated with many environmental and lifestyle factors, 
including obesity (Revesz, Milaneschi, Verhoeven, Lin, & Penninx, 2015), low physical 
activity (Cherkas et al., 2008), poverty and educational status (Arline T. Geronimus et al., 
2015), stress (Epel et al., 2004), and smoking (Huzen et al., 2014). Shorter telomere 
length has also been associated with chronic disease states such as cardiovascular disease 
(Fitzpatrick et al., 2007), hypertension (Samani, Boultby, Butler, Thompson, & Goodall, 
2001), type 2 diabetes (Willeit et al., 2014; Zhao et al., 2014), Alzheimer’s disease 
(Panossian et al., 2003), and certain cancers (Willeit et al., 2010) independent of 
chronological age. The disputable issue of whether telomere length is causal or 
consequential of aging remains elusive. Nonetheless, evidence indicates that telomere 
length is a key trademark of aging (López-Otín, Blasco, Partridge, Serrano, & Kroemer, 
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2013). An observation that has paved the way for its use in epidemiological research 
investigating the role of telomere length in predicting disease and mortality, as well as 
whether it can be altered by lifestyle and dietary modifications.  
b. Physical Activity  
 
Environmental and lifestyle factors have been investigated for their association 
with telomere length in numerous studies. Research supports the role of physical activity 
(PA) and numerous health benefits. Thus, a positive association between PA and 
telomere length has been proposed (Cherkas et al., 2008). In an effort to critically assess 
the data on PA and telomere length, a systematic review and meta-analysis on the subject 
was conducted (Mundstock et al., 2015). The authors included 37 original studies in the 
systematic review (n=41,230), and 25 had sufficient data to be included in the meta-
analysis, 11 of which specifically evaluated the correlation between the level of PA and 
telomere length. Of the 37 studies in the systematic review, 15 demonstrated a positive 
association between reported PA and telomere length, 14 of which were significant. The 
authors state that based on their results, there was not enough good-quality evidence to 
clearly establish an association between PA and telomere length. The meta-analysis 
demonstrated a difference in the standard means between the active and inactive groups 
of 0.91 (95% CI 0.48-1.35) in favor of the active group, however, this was not 
statistically significant. This systematic review and meta-analysis was limited primarily 
due to the moderate quality and methodological limitations of the included studies. There 
was high heterogeneity in the meta-analysis likely due to the differences in 
methodological techniques including measurement of telomere length, lack of controls, 
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poor information on potential confounding variables, and the instruments used in 
determining the level of PA (Mundstock et al., 2015).    
c. Obesity  
 To assess the effects of obesity on telomere length, investigators screened 789 
potential unduplicated articles and conducted a systematic review and meta-analysis on 
the data. Of these, 716 studies were excluded for various reasons including missing data 
and not meeting inclusion criteria. Sixty-three studies were included with data on 119,439 
participants. Of the studies examined, 24 did not find significant results, while the 
remaining 39 found a statistically significant association between obesity and telomere 
length (38 of which had an inverse relationship). The meta-analysis of studies reporting 
an association between body mass index (BMI) and telomere length yielded a trend for a 
weak inverse correlation. As in the previous systematic review on physical activity, this 
study also reported high heterogeneity indicating the results should be considered with 
caution. The question on a causal relationship between obesity and telomere length 
remains elusive.   
d. Smoking 
Poorer health outcomes have long been attributed to smoking status. In the mid-
1980’s Nakayama et al. noted that smoking resulted in single-strand breaks in human 
DNA (Nakayama, Kaneko, Kodama, & Nagata, 1985). In a recent paper, investigators 
looked at the effects of smoking as well as other metabolic traits (waist circumference, 
cholesterol levels, blood glucose levels, and blood pressure) on telomere length. Active 
smoking increased the yearly telomere attrition rate by more than three-fold (Huzen et al., 
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2014).   The authors also mention that for subjects who were former smokers, their 
annual attrition rate was comparable to subjects who never smoked.  
In addition to smoking, the authors found evidence supporting longitudinal 
associations between accelerated telomere loss and high blood pressure, elevated glucose 
levels and increased waist circumference (Huzen et al., 2014). These findings support the 
hypothesis that certain modifiable lifestyle factors impact the speed of biological aging 
and could provide a plausible mechanistic link to many age-associated diseases. Future 
prospective research is needed to determine if modifying telomere length could influence 
healthy aging and the associated disease states.  
e. Indicators of Socioeconomic Status 
 
As with other environmental factors, previous studies have shown an association 
between indicators of socioeconomic status (SES) and morbidity and mortality (Adler & 
Rehkopf, 2008). SES is often measured via numerous indicators such as education, 
income, social class, and occupation, depending on the available data, research question, 
and/or geographical location (Robertson et al., 2013). These assessments are considered 
broad indicators of SES and often used interchangeably. Education, however, has been 
hypothesized as being a better indicator of SES in adulthood, and thus a superior marker 
for identifying an association between SES and telomere length. Effects of SES on 
telomere length may take years to accumulate; therefore, education may best represent 
the time during early adult life through middle age more so than present day indicators 
(Steptoe et al., 2011).  
Several studies have investigated the association of telomere length and indicators 
of SES. In one study, researchers examined 70 children (35 white, 35 black) with ages 
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ranging from 7 to 12.6 years, who were randomly selected from a larger pool of 360 
children (120 white, 120 black, 120 Latino) (Needham, Fernandez, Lin, Epel, & 
Blackburn, 2012). SES measures included parental education level and household 
income. Children living in the lowest income households (<$40,000/year) tended to have 
a lower T/S ratio compared to children living in the highest income families 
(≥$70,000/year) (β = -0.38; 95% CI: -0.82, 0.06; p = 0.09) (Needham et al., 2012).        
Needham and colleagues also utilized data from the National Health and Nutrition 
Examination Survey (NHANES) and investigated the association between SES, health 
behaviors and telomere length (Needham et al., 2013). The authors used education level 
and household income as indicators for SES, as well as BMI, smoking, alcohol and 
physical activity (PA) as indicators for health behaviors. Telomere lengths of respondents 
who did not graduate from high school were approximately 4% shorter than those who 
graduated from college (p<0.01) (Needham et al., 2012). This corresponded to a 
difference of 102 base pairs (bp), which given the model-based estimate of age-
associated telomere shortening of 14.6 bp/year, was roughly equivalent to seven years of 
additional aging.  The authors found no association between income and telomere length.  
Despite the association found from this large, nationally representative sample, a 
systematic review and three separate meta-analyses of 29 unique studies found no 
evidence for an association between SES and telomere length.  However, the meta-
analysis on education confirmed that high (compared to low) education was weakly 
associated with longer telomere length (Robertson et al., 2013). Notably, there was 
significant heterogeneity among the studies. Although these analyses provide an 
indication to support a positive relationship between education and telomere length, they 
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fail to provide conclusive evidence of an association between all SES indicators and 
telomere length, warranting further investigation.  
f. Stress and Mental Health  
Epidemiological studies have investigated an association between stress and 
chronic mental states, such as depression and anxiety disorders, as well as, cardiovascular 
disease and type 2 diabetes. Data from the 1999-2002 cycles of NHANES yielded an 
association between telomere length and mental health disorders (Needham et al., 2015). 
After controlling for age, gender, and race/ethnicity, no associations between depression 
or anxiety status and telomere length were found in a sample of 1,164 participants. When 
stratified on gender (a known confounding variable), generalized anxiety disorder / panic 
disorder was significantly associated with shorter telomere length in women (β: -0.26), 
but not in men (β: -0.00). In addition, the researchers found that severe depressive 
symptomatology (identified by antidepressant use) was associated with shorter telomere 
length even in early adulthood. The authors state that their study was marginally 
underpowered (Needham et al., 2015).  
Investigators of another study looked at the association of racial discrimination 
and mental health on telomere length in a sample of 95 African American men (Chae et 
al., 2016).   After controlling for sociodemographic factors, greater anxiety symptoms 
were associated with shorter telomere length (β: -0.29, SE = 0.014, p <0.05).  In addition, 
there was a significant interaction between racial discrimination and depression 
predicting telomere length with reported racial discrimination being associated with 
shorter telomere length among those with lower levels of depressive symptoms (β: 0.011, 
SE = 0.005, p <0.02). As hypothesized, participants reporting low levels of racial 
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discrimination along with lower levels of depressive symptoms, had a longer mean 
telomere length (Chae et al., 2016).  
g. Oxidative Stress  
 
Of the proposed mechanisms relating stress and overall health, alterations in the 
hypothalamic-pituitary-adrenal (HPA) axis and the immune system are of relevant 
interest as inflammation is a key biological mediator of morbidity and mortality. 
Inflammation is known to trigger T-cell proliferation, which is linked to telomeric 
shortening (Kiecolt-Glaser et al., 2013). Inflammation can also result in oxidative stress, 
defined as “a disturbance in the balance between the production of reactive oxygen 
species (ROS) and antioxidant defenses” that may lead to tissue injury (Betteridge, 2000). 
Production of ROS, such as the hydroxyl radical (●OH) and superoxide anion (O2
●-), is an 
unavoidable circumstance of the body’s biochemical processes. These free radicals are 
unstable due to the presence of unpaired electrons and can start a chain of events 
ultimately leading to cell damage. Antioxidant defenses are the body’s primary protection 
against tissue injury. Chronic low levels of oxidative stress can cause DNA damage, 
resulting in single-strand breaks (Petersen, Saretzki, & Zglinicki, 1998). Telomeres are 
particularly susceptible to oxidative damage given their guanine-rich ends (Von 
Zglinicki, 2002). This author noted that the loss of protective telomeres may result in 
chromosome instability, fusion with neighboring chromosomal ends and double-strand 
breaks in DNA.  
A reduction in oxidative stress leads to a decreased rate of telomeric shortening 
and postponement of cell senescence (Sitte, Saretzki, & Von Zglinicki, 1998). As both an 
indicator of oxidative stress and cell senescence, telomere length has emerged as a 
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potential biomarker of biological, as well as functional aging. Dysfunctional telomeres 
are linked to development of chronic pathologies including cardiovascular disease, type 2 
diabetes, hypertension, Alzheimer’s disease and certain cancers (Paul, 2011).  
 
B. Health Outcomes and Telomere Length 
1. Cardiovascular Disease 
A systematic review and meta-analysis was conducted investigating telomere 
length and risk of cardiovascular disease (CVD) (Haycock et al., 2014). The authors 
focused on prospective and retrospective studies involving coronary heart disease (CHD) 
and/or cerebrovascular disease. In all, 24 studies (12 prospective, 12 retrospective) 
involving 43,725 participants (8400 with CVD) were investigated. The heterogeneity in 
telomere length were reported to be attributable to the quality, size, and age variability. 
The pooled relative risk (RR) for CHD comparing the subjects with the shortest third of 
telomere length to the subjects in the group with the longest third of telomere length was 
1.54 (95% CI: 1.30, 1.83; 20 studies) with moderate heterogeneity (I2 = 64%) (Haycock 
et al., 2014).  Additionally, the pooled RR for cerebrovascular disease for shortest third 
vs longest third of telomere length using information from 10 studies (4 retrospective, 6 
prospective) after adjusting for multiple factors was 1.42 (95% CI: 1.11, 1.81) with no 
significant heterogeneity present (Haycock et al., 2014).  
Results from this meta-analysis indicate an inverse association between telomere 
length and risk of CHD independent of conventional vascular risk factors. The 
association between telomere length and cerebrovascular disease was comparable; 
however, it was not significant in the meta-analyses restricted to the prospective studies 
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or the higher quality studies. The authors indicated further well-designed, prospective 
studies are warranted to determine causality. They speculate that one mechanism for a 
causal association between shorter telomeres and increased CVD risk could be the 
accumulation of senescent cells, which are a prominent feature of atherosclerotic plaque. 
This cell accumulation promotes apoptosis, which can further exacerbate inflammation 
and endothelial dysfunction (Haycock et al., 2014).  
 
2. Type 2 Diabetes Mellitus 
Data from the Danish Twin Registry was used to investigate the association 
between development of insulin resistance and telomere length (Verhulst et al., 2016). 
The authors analyzed data from 338 same-sex twin pairs who participated in a 12-year 
longitudinal study on cardiovascular risk factors. Plasma glucose, cholesterol and 
triglyceride levels, and serum insulin were measured, and HOMA-IR was calculated as a 
measure of insulin resistance. Baseline insulin resistance was not associated with 
telomere length attrition at follow-up; however, shorter telomere length at baseline was 
associated with an increased development of insulin resistance at follow-up (p<0.0001). 
These data support the hypothesis that those who have a shorter telomere length in young 
adulthood may be more susceptible to developing insulin resistance and conceivably type 
2 diabetes at a younger age compared to their peers with a longer telomere length.  
Similar results were found from a prospective cohort of 2,328 Native Americans, 
a population with a disproportionately high prevalence of diabetes (Zhao et al., 2014). At 
baseline, diabetic participants had a significantly shorter mean telomere length, higher 
body mass index (BMI), larger waist circumference (wc), higher systolic blood pressure, 
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higher triglycerides, and higher highly-sensitive C-reactive protein (hsCRP). After 
adjusting for age and other covariates, the inverse associations between telomere length 
and BMI (r=-0.121), wc (r=-0.154), and hsCRP (r=-0.089) remained significant (Zhao et 
al., 2014).  
Among the 2,328 initially non-diabetic participants, 292 developed type 2 
diabetes (T2DM) at the end of the five-year follow up (12.5%). After adjusting for 
covariates, those that developed T2DM had a significantly shorter mean telomere length 
at baseline (mean T/S ratio 0.96 vs. 1.02) compared to those who remained free of the 
disease (p = 0.007).  Adjusted cox spline regression analysis, using telomere length as a 
continuous variable, indicated that a longer mean telomere length was significantly 
associated with a reduced risk of T2DM (β = -2.78; HR 0.06 [95% CI: 0.01, 0.42], 
p=0.004) (Zhao et al., 2014). The results demonstrated that those in the shortest quartile 
for telomere length had a nearly two-fold increased risk of developing T2DM compared 
to the those in the longest quartile (HR 1.83 [95% CI: 1.26-2.66], p<0.0001) (Zhao et al., 
2014).  
In a separate prospective study, 1000 participants were followed every five years 
for 15 years, with a 90% participation rate (Willeit et al., 2014).  Leucocyte telomere 
length from three time points were collected and analyzed (1995, n=684; 2005, n=558; 
2010, n=479). Of the 606 participants who were free of T2DM at the start of the study, 44 
went on to develop the disease (7.3%). The authors reported an adjusted hazard ratio 
(HR) for T2DM of 2.00 (95% CI: 0.90, 4.49; p = 0.091) comparing the shortest telomere 
length quartile to the longest. When combining the top three quartiles and comparing 
them to the shortest, they reported a HR of 2.31 (95% CI: 1.21, 4.41; p = 0.011) (Willeit 
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et al., 2014). The authors also conducted a literature-based meta-analysis of three relevant 
prospective studies, including the previously discussed study by Zhao and colleagues. 
The pooled studies included 6,991 participants and 2,011 incident cases of T2DM. The 
pooled RR for comparison of the shortest telomere length quartile at baseline with the 
longest was 1.31 (95% CI: 1.07, 1.60; p=0.01; I2 = 69%) (Willeit et al., 2014). The 
authors report that shorter relative telomere length is independently associated with the 
increased risk of T2DM; however, a causal involvement of telomeres in the disease 
development remains elusive (Willeit et al., 2014).  
3. Cancer 
 
Attention was given to a 2009 publication by Hou et al. for their proposition that 
shortened telomere length is a risk factor for gastric cancer (Hou et al., 2009). The 
authors conducted a population-based case-control study in Warsaw, Poland between 
1994 and 1996. Telomere length was measured using quantitative real-time polymerase 
chain reaction (qPCR) in 300 cases of gastric cancer and 416 age- and sex-matched 
controls, investigating the association between telomere length and risk of gastric cancer, 
as well as confounders and risk modifiers for telomere length-related risk. Data on 
education level, BMI, smoking status, alcohol intake, calorie intake, dietary patterns 
including fruit and vegetable intake, red meats, sausage, and preserved vegetables, as 
well as H. pylori infection status and familial history of cancer were included in the 
analyses.     
As expected, when compared to the controls, cases had lower levels of education, 
drank more alcohol, smoked more cigarettes, consumed fewer vegetables, and had greater 
familial history of gastric cancer. With regards to telomere length, cases of gastric cancer 
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had significantly shorter telomere length compared to controls. Unconditional logistic 
regression analysis of telomere length in quartiles, demonstrated that the risk of gastric 
cancer was doubled for cases in the lowest quartile of telomere length compared to those 
in the highest quartile (OR=2.04; 95%CI: 1.33, 3.13) even after adjusting for many 
potentially confounding factors (Hou et al., 2009).  
A similar study was conducted investigating telomere length and risk of gastric 
cancer (Liu et al., 2009). The authors reported that after adjusting for confounding 
factors, individuals with a shorter telomere length had a two-fold increased risk of gastric 
cancer (OR = 2.14, 95% CI: 1.52, 2.93) (Liu et al., 2009). The authors also observed a 
dose-response relationship with risk of gastric cancer within the quartiles of telomere 
length. With the lowest quartile being the referent group, the second, third, and fourth 
quartiles had a subsequent increased risk of gastric cancer with an OR of 1.45 (95% CI: 
0.97, 2.23), 2.11 (95% CI: 1.36, 3.24), and 3.12 (95% CI: 2.01, 4.79), respectively (Liu et 
al., 2009). The results of these two studies on telomere length and gastric cancer are in 
agreement with other studies of telomere length and cancer, including cancers of the 
bladder (Broberg, Björk, Paulsson, Höglund, & Albin, 2005; McGrath, Wong, Michaud, 
Hunter, & De Vivo, 2007), lung (Jang et al., 2008), kidney (Pal et al., 2015), and 
pancreas (Skinner et al., 2012).  
Among renal cell carcinoma (RCC) cases, data suggested significantly shorter 
telomere lengths within the RCC tissue compared to normal adjacent renal tissue from 
the same subject (p = 0.000) (Pal et al., 2015).  Low grade tumors (grades I & II) had 
significantly longer telomere lengths than high grade tumors (grades III & IV) (p= 
0.016), indicative of extensive cell proliferation. The authors suggest their findings 
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support the view that shorter telomere length is in part, responsible for early development 
and aggressiveness of the tumor, and that telomere length and telomerase activity can be 
used as predictive and diagnostic markers of cancer (Pal et al., 2015).    
A U-shaped phenomenon has also been observed in studies investigating telomere 
length and cancer. Data from a case-control study on telomere length and gastric cancer 
risk in a Chinese population demonstrated an increased risk of gastric cancer associated 
with both shorter and longer telomere lengths (Du et al., 2015). The study population 
consisted of 1136 cases of gastric cancer along with 1012 age- and gender-matched 
cancer-free controls. The researchers separated the groups into a quintile distribution of 
relative telomere length (RTL) for analyses. The first quintile contained those with the 
longest RTL, while the second quintile was the referent group. There was a dose-
response increased risk of gastric cancer observed in the third, fourth, and fifth groups 
with odds ratios of 1.28 (95% CI 0.93, 1.77), 1.65 (95% CI: 1.21, 2.26), and 3.81 (95% 
CI: 2.82, 5.13), respectively when compared to the referent group (Du et al., 2015). 
Interestingly, the first quintile, those with the longest RTL, had an OR of 1.78 (95% CI: 
1.30, 2.44). Thus, a near two-fold increased risk of gastric cancer was found among those 
with the longest telomere length (Du et al., 2015).  
U-shaped results have also been reported in other studies involving telomere 
length and cancer.  Investigators observed a linear trend for a higher risk of pancreatic 
cancer associated with a shorter mean telomere length where the overall result was a 
skewed U-shaped relationship between telomere length and prevalence of pancreatic 
cancer (Skinner et al., 2012).   
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Other studies have reported finding associations of longer telomere length with 
cancer. Investigators conducted a case-control study in women looking at telomere length 
and risk of breast cancer among 265 cases and 446 controls (Svenson et al., 2008). Blood 
cell telomeres were longer in the cases compared to the controls. In determining 
associated risk of breast cancer, the groups were divided into quartiles based on relative 
telomere length (RTL) distribution among the controls. Breast cancer risk increased in 
the second, third, and fourth quartiles compared to the referent group (Ptrend < 0.001), 
with an OR of 5.17 (95% CI: 3.09, 8.64) in the quartile with the longest telomeres 
(Svenson et al., 2008). The researchers also examined RTL as a predictor of survival. The 
cases were dichotomized into two groups based on the median RTL value of 0.73. 
Patients under 50 years of age with shorter telomeres had a significantly better outcome 
than patients with telomeres longer than the median value (p = 0.024). For patients 50 
years and older, a borderline value was observed (p = 0.095). Overall, the investigators 
determined that RTL was found to represent a strong independent prognostic indicator in 
patients with advanced breast cancer.   
 
4. Alzheimer’s Disease and Cognitive Decline 
Cognitive decline, including dementia and Alzheimer’s disease, is highly 
associated with the aging process and is significantly modified by genetic and 
environmental factors. A study in a cohort of elderly Chinese men looked at telomere 
length and cognitive function (Ma et al., 2013). The 976 participants were originally 
recruited for a health survey in Hong Kong between 2001 and 2003 where they were 
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screened for cognitive function via the Mini-Mental State Examination (MMSE), as well 
as the Community Screening Interview for Dementia.  
Participants were divided into tertiles based on mean telomere lengths of short 
(7.20 kb, n = 335), medium (8.85 kb, n = 369) and long (11.00 kb, n = 251). No 
association was found between telomere length and MMSE score; however, subjects in 
the medium and long telomere length groups performed significantly better in the 
episodic memory challenge (r=0.086, p=0.007), as well as the executive function measure 
of verbal fluency (r=-0.053, p=0.048) after adjusting for age and education level (Ma et 
al., 2013).  
When subjects were divided by MMSE score using the accepted cutoff for 
cognitive impairment (>24 vs ≤ 24), those below the cutoff had a mean telomere length 
251 base pairs (bp) shorter than those with an MMSE score above the cutoff (p = 0.04). 
Additionally, when results from the three exams were combined, participants with all 
three test scores above the cutoff had a significantly longer mean telomere length (9.03 
kb, n=244) compared to those with no scores above the cutoff (8.67 kb, n=52) (Ma et al., 
2013). Notably, this study failed to control for potential factors associated with the 
outcome including BMI, co-morbidities, and smoking status.  
In a longitudinal study from the Lothian Birth Cohorts 1936 and 1921, data were 
used to investigate telomere length and cognitive decline later in life (Harris et al., 2016). 
Blood samples, as well as physical and cognitive exams were collected and analyzed at 
multiple timepoints throughout the study. Quantitative PCR was used to analyze telomere 
length. Linear mixed models were used to investigate change in telomere length, 
cognitive function and physical ability over time. In both cohorts, there was an overall 
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decrease in telomere length with age. Interestingly in both cohorts, telomere length was 
longer in males than in females (LBC1936 by 177.9 bp; LBC1921 by 256.9 bp). This 
finding is contrary to most data available on sex and telomere length (Gardner et al., 
2014). There was no evidence to indicate that baseline telomere length was associated 
with the course of physical and/or cognitive decline. Thus, the rate of telomere length 
decline did not correlate with the rate of decline in physical and/or cognitive function.  
The longitudinal design adds strength to the results. The investigators were able to 
utilize multiple time points throughout the duration to measure telomere length in aging 
adults. Nevertheless, this study experienced loss to follow up due to natural attrition in 
these aged cohorts (retention of 64% and 11%, respectively). The authors neglected to 
mention the possibility of survival bias, which may have impacted their findings and 
nullified their results. 
 
C. Micronutrients and Telomere Length 
1. Overview of Dietary Intake and Telomere Length 
 
It is well known that numerous dietary factors influence the risk of chronic 
disease, but the mechanisms of action by which micronutrients influence chronic disease 
outcome are complex and uncertain in most cases. Moreover, little is known about the 
association of telomere length and micronutrient status in adults. In a study of 56 middle-
aged Italian subjects, Marcon and colleagues found a significant correlation between 
mean telomere length and dietary intake of micronutrients, based on a food frequency 
questionnaire (FFQ) developed for Italian dietary habits (Marcon et al., 2012). The 
authors reported that vegetable intake was significantly and positively associated with 
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mean telomere length after adjusting for age (p=0.013), with strong associations also 
found among the antioxidants beta-carotene (p=0.001), vitamin A (p=0.001), vitamin C 
(p=0.016), vitamin E (p=0.014), as well as folic acid intakes (p=0.019) (Marcon et al., 
2012). In this study, the term folic acid was used to represent folate for which intake was 
determined based on consumption of dark leafy greens, categorized as “spinaches” by the 
researchers. Currently, cereal grains are not fortified with folic acid in Italy, and only a 
limited number of commodity items available, such as corn flakes, have been fortified 
with folic acid.  
 Interestingly, when the women were dichotomized on age (above and below the 
mean age of 56 years), beta-carotene appeared to be protective against telomere attrition 
only in the younger women (p=0.009) (Marcon et al., 2012). This observation supports 
the role of dietary factors, specifically antioxidants, in diminishing oxidative damage to 
telomeres in younger individuals. Notably, this study did not investigate biomarkers for 
any of the micronutrients. Nonetheless, the authors referenced a study which found a 
significant correlation between the dietary FFQ used and blood micronutrient levels. 
However, the use of “spinaches” as a dietary marker of folate intake alone is limiting. 
Dark leafy greens are rich in numerous micronutrients and phytochemicals. The 
possibility remains that the correlation between “folate” intake and telomere length 
proposed by the authors may be due to other nutritive components in the dark leafy 
greens, and not limited to folate itself.  
In another study, Xu et al. investigated multivitamin use and telomere length in 
586 women 35 to 74 years of age  (2009). The authors reported that in general, 
multivitamin use was associated with longer telomere length, and compared to non-users, 
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daily users had on average 5.1% longer telomeres (Ptrend = 0.002). Statistically, this 
difference corresponded to approximately 9.8 years of age-related telomere loss. Once-a-
day multivitamins and the antioxidant combination supplements were also significantly 
associated with telomere length (Ptrend = 0.01, Ptrend = 0.009, respectively); however, the 
authors found no association between the Stress-tabs or B-complex use category and 
telomere length (Ptrend=0.5). When individual micronutrient supplements were 
investigated, only vitamin B12 and iron use demonstrated significant findings. Vitamin 
B12 users (n = 52) had significantly longer telomere lengths (p = 0.03) compared to non-
users of vitamin B12 supplements (n = 518). In addition, iron users (n=41) had 
significantly shorter telomere lengths (p = 0.007) compared to non-users of iron 
supplements (n = 527). Although most micronutrient intakes from food in the Xu study 
were positively associated with telomere length, most became nonsignificant when 
adjusted for multivitamin use. Nonetheless, among the women who did not use 
multivitamins (n = 203), higher dietary intakes of beta-carotene (p = 0.045), folate (p = 
0.02), magnesium (p = 0.04), vitamin C (p = 0.002), vitamin A (p = 0.008), and vitamin E 
(p = 0.03) were significantly associated with longer telomere length (Xu et al., 2009).   
Similarly, Garcia-Calzon and associates reported diets higher in antioxidants were 
significantly associated with longer telomere length (García-Calzón, Moleres, et al., 
2015). The authors demonstrated that dietary total antioxidant capacity (TAC) was 
positively correlated with longer telomere length in Spanish children ages 6 to 18 years (p 
= 0.007) after adjusting for covariates. In addition, higher intakes of legumes and PUFAs 
were positively associated with longer telomere length (p = 0.032 and p = 0.019, 
respectively), while diets higher in cereals and white bread were significantly associated 
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with shorter telomere length (p = 0.002 and p = 0.002, respectively), even after adjusting 
for potential confounders (García-Calzón et al., 2015).      
2. Iron Status and Telomere Length 
 The average human body contains approximately two to four grams of iron. 
Although iron is found in numerous food sources, the typical American diet consists of 
only five to seven mg/1000 kcal in both a heme and nonheme form. Heme iron is that 
which is bound to the porphyrin ring structure and derived from hemoglobin and 
myoglobin sources found in animal products. Nonheme iron is sourced primarily from 
plant foods including leafy greens, nuts, legumes, grains, fruits and vegetables (Gropper, 
Smith, & Groff, 2009a).  
 Digestion and absorption of the two forms differ; thus, dietary intakes and 
restrictions can substantially influence iron stores. Heme iron is first hydrolyzed in the 
stomach and small intestine to release the heme-porphyrin ring (also known as 
metalloporphyrin) from the globin complex. Heme is readily absorbed across the brush 
border of the enterocyte by a heme carrier protein (hcp1), primarily in the duodenal 
region of the small intestine.  
 Nonheme iron must be enzymatically released from food to be absorbed. Most 
nonheme iron from plant sources is in the ferric (+3) form, which is soluble under acidic 
conditions, such as in stomach acid. However, once chyme passes into the small intestine, 
the alkaline pancreatic secretions may cause ferric iron to form ferric hydroxide 
(Fe(OH)3), an insoluble, less bioavailable iron complex. Ferrireductases, such as Dcytb, 
on the brush border in the duodenum function to reduce ferric iron to the more soluble 
ferrous state. Vitamin C appears necessary for the reductase activity. Ferrous iron from 
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nonheme sources crosses the brush border via the divalent mineral transporter 1 (DMT1) 
in the duodenal portion of the small intestine. DMT1 also transport other minerals such as 
zinc, manganese, copper, nickel, and lead.  
 Within the enterocyte, ferrous iron (Fe+2) binds to compounds (chelators and 
ligands) which determine iron’s fate depending on the binding nature of the 
chelator/ligand. Iron can be used by the mucosal wall, sloughed off within the cell and 
excreted into the feces, or transported out and used by other body tissues. Absorption 
enhancers for nonheme iron include sugars, such as fructose, acids, such as citric acid and 
ascorbic acid, as well as products of meat digestion. Dietary factors inhibiting nonheme 
iron absorption include polyphenols (tannin derivatives), oxalates from foods such as 
spinach, berries and chocolate, phytates from corn, whole grains and legumes, as well as 
other minerals including calcium, zinc and copper (Gropper et al., 2009a).  
Nearly 65% of iron in the body is associated with hemoglobin; however, the 
importance of iron extends well beyond its oxygen carrying ability. The remaining iron is 
stored in hepatocytes as ferritin and hemosiderin (as Fe+3), or in the spleen, bone marrow, 
and/or muscle tissue, as well as being a part of enzymes. Iron is involved in numerous 
metabolic processes as a part of heme in a cluster with sulfur, or by itself. It functions as 
a component of proteins involved in DNA synthesis, such as ribonucleotide reductase, 
and part of the catalytic site of cytochromes and peroxidases. Iron also acts as a cofactor 
for dozens of enzymes, including the reactive oxygen species (ROS) quenching enzymes 
catalase and myeloperoxidase (Gropper et al., 2009a).  
Reactive oxygen species such as the superoxide radical (O2
●), hydroxyl radical 
(●OH), and hydrogen peroxide (H2O2) are generated in the body and are typically 
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quenched by antioxidants and/or enzymes. However, a disruption in the equilibrium and 
subsequent ROS overload, can result in oxidative damage. Ferric iron (Fe+2) is released in 
high concentrations from lysosomal apoptosis resulting from the cell damage. This 
excessive free ferrous iron can be a catalyst for further reactions (i.e., Fenton reaction) 
from which ROS are formed; thus perpetuating the cycle and leading to oxidative stress 
(Kepinska, Szyller, & Milnerowicz, 2015).  
Antioxidants appear to have a protective effect and have been associated with 
longer telomere length (García-Calzón et al., 2015; Xu et al., 2009). Iron has the unique 
properties of being involved in both anti-oxidative and pro-oxidative reactions (Pra, 
Franke, Henriques, & Fenech, 2012). It is also a key trace element in nucleic acid 
metabolism, including nucleotide synthesis, as well as DNA synthesis and repair (Pra et 
al., 2012). Iron is a co-factor in DNA polymerases, DNA helicases, and the DNA primase 
regulator subunit PRIM2 (Zhang, 2014). Iron deficiency, as well as iron overload, is 
associated with genomic instability. Iron deficiency anemia increases nuclear DNA 
damage in adults  (Zhang, 2014). Thus, both conditions have the potential to have a 
detrimental effect on telomere length. To our knowledge, no study has investigated the 
impact of iron deficiency on telomere length.  
a. Iron Status and Telomere Length 
The findings on iron supplementation by Xu et al. (Xu et al., 2009) were in 
agreement with data reported by Mainous and colleagues in which elevated serum 
biochemical tests of iron status were significantly associated with shorter telomere 
lengths (p < 0.0001), likely due to the highly oxidative nature of iron (Mainous III et al., 
2013). From the available data on 511 men and women, the authors investigated both 
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phenotype (serum ferritin >1000 ng/mL) and HFE genotype (gene for hemochromatosis) 
markers of iron status. The researchers found that an elevated iron phenotype, but not 
hemochromatosis genotype, was significantly associated with a shorter telomere length in 
both the crude and adjusted models (Mainous III et al., 2013).  
Furthermore, in a subsequent study by Mainous et al. (2014), investigating iron 
status, telomere length and quality of life in 669 participants, the researchers reported that 
in the unadjusted model, overall general health (p<0.001) and mental health (p<0.01) 
statuses were significantly worse among those with elevated transferrin saturation 
percentage (TS%) (≥50% for men, ≥45% for women) compared to non-elevated TS% 
(<50% for men, <45% for women).  Additionally, telomere length was significantly 
shorter (p<0.01) in those with elevated TS% compared to the non-elevated TS% subjects. 
After adjusting for demographics and socio-economic status, those with elevated TS% 
had poorer mental health status and shorter telomere length compared to the non-elevated 
TS group, (p<0.001 and p<0.01, respectively). In the fully adjusted model (additional 
adjustments for chronic disease states), significantly poorer mental health status remained 
among those in the elevated TS% group (p<0.0001), as was a trend toward shorter 
telomere length (p<0.05) (Mainous III et al., 2014).   
Kozlitina and colleagues investigated the association of parameters of red blood 
cell size and telomere length in a cohort of 3,157 individuals (Kozlitina & Garcia, 2012). 
After adjusting for potential confounding variables (age, gender, and ethnicity), the 
investigators found a strong, significant association between the size of the red blood cell 
measured by mean corpuscular volume (MCV), as well as the RBC distribution width 
(RDW), and a shorter mean telomere length (p<0.0001, p<0.0001, respectively). In 
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addition, they observed that higher hemoglobin levels were also associated with shorter 
telomere length (p=0.0009) in this population. However, contrary to the findings by 
Mainous et al. (2014), the authors did not find an association between telomere length 
and iron stores. Although the authors do not speculate, it is well known that iron, as well 
as, vitamin B12 and folate are key micronutrients involved in red blood cell (RBC) 
production. Thus, higher hemoglobin could potentially correlate with elevated iron in the 
erythrocyte, just as elevated MCV and RDW correlate with vitamin B12 and folate 
deficiency (Kepinska et al., 2015).  
It is well understood that an insufficiency of vitamin B12 and/or folate can result 
in macrocytic red blood cells, identified hematologically by elevated MCV and RDW. 
While the authors reported an association between elevated MCV, greater RDW and a 
shorter telomere length, they did not investigate the status of other micronutrients 
involved, such as vitamin B12 and folate (Kozlitina & Garcia, 2012). Interestingly, 
homocysteine levels were higher in the shortest tertile of telomere length compared to the 
longest (p=0.0054); however, after full adjustment, the association lost significance. 
Homocysteine is known to be elevated in both folate and vitamin B12 deficiency. This 
study demonstrated strength in sample size, although it was limited by design having 
originated as a cross sectional study in 2000, and later transformed to a longitudinal study 
in 2007 (Kozlitina & Garcia, 2012). 
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3. Factors in One-Carbon Metabolism 
 
a. Overview 
 
The requirement of vitamin B12 for folate metabolism has been well established. 
Vitamin B12 in the form of methylcobalamin serves as a coenzyme in the conversion of 
homocysteine to methionine (Fig.1). The formation of methylcobalamin requires a 
methyl group from folate in the form of 5-methyl tetrahydrofolate (5-MTHF). The 
enzyme Methionine Synthase bound to cobalamin picks up the methyl group from 5-
MTHF forming methylcobalamin and tetrahydrofolate (THF). In this process, the methyl 
group from the newly formed methylcobalamin is transferred to homocysteine converting 
it into methionine. The formation of 5-MTHF is irreversible, thus a deficiency in vitamin 
B12 traps folate in this methylate form, commonly referred to as the “methyl-folate trap.” 
With adequate vitamin B12 status, folate as THF, is available as a substrate for its other 
coenzyme forms such as, 10-formyl THF which is required for purine synthesis, and 
5,10-methylene THF required for thymidylate synthesis essential for DNA synthesis 
(Gropper, Smith, & Groff, 2009b).  
Homocysteine (Hcy) is a non-protein forming amino acid that acts as a methyl 
carrier in folate metabolism. After synthesis, methionine is activated by ATP to form S-
adenosylmethionine (SAMe) which serves primarily as a universal methyl donor in 
numerous reactions throughout the body. The post-methylation byproduct, S-
adenosylhomocysteine (SAH), is subsequently hydrolyzed to Hcy. Homocysteine is then 
ready to accept another methyl group from the Methionine Synthase–Vitamin B12 
complex and repeat the cycle. Via a transsulfuration pathway, catalyzed by cystathionine 
β-synthase requiring pyridoxal-5’-phosphate (PLP), homocysteine irreversibly condenses 
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with serine to form cystathionine which is further hydrolyzed by a second PLP-dependent 
enzyme, gamma-cystathionase, to form cysteine and α-ketobutyrate.   
Elevated blood Hcy, or hyperhomocysteinemia, has long been considered a risk 
factor for deleterious health outcomes, particularly cardiovascular disease (Reynolds, 
2006). Much research on this subject culminated in a prominent meta-analysis in which 
included 27 studies involving over 4,000 patients with occlusive vascular disease 
(including cardiovascular, peripheral, and cerebrovascular), and over 4,000 healthy 
controls (Boushey, Beresford, Omenn, & Motulsky, 1995). Data showed that Hcy was an 
independent risk factor for atherosclerotic vascular disease, specifically, of the coronary, 
cerebral, and peripheral vessels.  
Subsequent studies have gone on to further demonstrate an indisputable link 
between elevated Hcy and an increased risk of disease. One study out of the Framingham 
Heart Study showed that among 1933 elderly subjects, those with elevated Hcy (upper 
quartile) had a greater than two-fold increase in all-cause cardiovascular disease mortality 
compared to those with lower Hcy levels (lower three quartiles) (RR = 2.18; 95% CI: 
1.86, 2.56) (Bostom et al., 1999). The association attenuated but remained significant 
after adjusting for multiple factors including age, sex, systolic blood pressure, smoking, 
diabetes, and cholesterol levels (RR = 1.54; 95% CI: 1.31, 1.82) (Bostom et al., 1999).    
 
b. Folate, Vitamin B12, and Homocysteine 
As previously discussed, vitamin B12 is a key nutrient in the methylation of 
homocysteine to methionine, and therefore plays an essential role in the reduction of Hcy 
levels. With the substantial reduction of folate deficiency following folic acid 
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fortification, it remains plausible that prevalent cases of hyperhomocysteinemia are 
related primarily to vitamin B12 deficiency, particularly among the elderly who are at the 
greatest risk of deficiency due to the higher incidence of pernicious anemia and 
malabsorption with increased age.   
In a prospective study of 1096 older Latino adults shortly after fortification with 
folic acid was in full operation, hyperhomocysteinemia was present in 181 subjects 
(16.5%) (Green & Miller, 2005). Of the 181 subjects, 55 (30.4%) had low total vitamin 
B12 and/or low holotranscobalamin (holoTC). HoloTC is a vitamin B12/carrier protein 
complex and used as a biomarker of B12 status. Thus, holoTC represents the biologically 
active fraction of vitamin B12 in the blood, suggesting it may be a more sensitive 
biomarker for the vitamin than serum levels alone.  Among these 55 participants, 29 
subjects were low in both vitamin B12 and holoTC. In contrast, only two (1.1%) of the 
181 participants with hyperhomocysteinemia had low RBC folate. Of these two subjects, 
both also had low vitamin B12 and/or low holoTC. According to the study, there was an 
8-fold risk of hyperhomocysteinemia because of low vitamin B12 (OR=8.3, 95% CI: 4.7-
14.6) and a population attributable risk (PAR%) of 29.7%. The odds for 
hyperhomocysteinemia associated with low RBC folate was negligible and nonsignificant 
(OR=1.5, 95% CI: 0.2-11.2) and a PAR% of 0.3. Thus, it can be suggested that in the age 
of folic acid fortification, hyperhomocysteinemia is more attributable to vitamin B12 
deficiency (29.7–36.4%) rather than a deficiency in folate (0.3%) (Green & Miller, 
2005).  
National Health and Nutrition Examination Survey (NHANES) data from 10,413 
participants were analyzed for serum vitamin B12 and folate concentrations, along with 
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Hcy and MMA (Selhub, Morris, & Jacques, 2007). Prevalence of vitamin B12 deficiency 
(defined as <148 pmol/L) was 1.6% to 2.2% in the NHANES III and 1999-2000 and 
2001-2002 cycles, respectively. The mean Hcy level decreased across increasing folate 
categories among those with sufficient vitamin B12 levels (≥ 148 pmol/L) in both 
NHANES surveys. Contrarily, the mean Hcy level for those who were vitamin B12 
deficient increased significantly across the four serum folate categories. Furthermore, the 
mean Hcy for the B12 deficient group with serum folate >32.6 nmol/L was nearly 12 
µmol/L, a commonly used cutoff point for hyperhomocysteinemia. In addition, among 
those with vitamin B12 deficiency in the NHANES 1999-2002 data, serum MMA 
concentrations increased significantly across all increasing categories of folate. A 
significant decrease in MMA was observed in subjects replete in vitamin B12 (>148 
pmol/L) with increasing concentrations of folate (Selhub et al., 2007).    
Elevated Hcy is indicative of impaired methionine synthase activity secondary to 
vitamin B12 deficiency, whereas high MMA levels reflect compromised methylmalonyl-
CoA mutase activity. These data conclude that both pathways of vitamin B12 metabolism 
are adversely impacted by elevated folate concentrations (Selhub et al., 2007). Therefore, 
these data suggest that the enzymatic functions of vitamin B12 deteriorate as serum folate 
concentrations increase, resulting in elevated MMA and Hcy, the later which is known to 
be detrimental to health and well-being (Selhub et al., 2007).  
 Data from the NHANES 1999-2000 and 2001-2002 cycles yielded an association 
between folate and B12 status in relation to anemia (n=1458) and cognitive impairment 
(n=1302) in older adults (Morris, Jacques, Rosenberg, & Selhub, 2007). The researchers 
defined low B12 status as a serum B12 <148 pmol/L or a serum MMA concentration of 
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>210 nmol/L. High folate status was defined as folate concentrations >59 nmol/L.  
Within the study population, nearly 3% were B12 deficient (serum B12 <148 pmol/L), 
however, 25% met the study criteria for low B12 status. High serum folate concentrations 
accounted for 4% of the study population.  
 In the fully adjusted model, participants with normal B12 status and high serum 
folate had a lower prevalence of anemia (OR: 0.6; 95% CI: 0.2, 2.4) and cognitive 
impairment (OR: 0.5; 95% CI: 0.2, 0.96) compared to those with normal status in both 
nutrients. Among those with low B12 status, those with normal serum folate levels had an 
almost 2-fold increased prevalence of anemia (OR: 1.9; CI: 1.01, 3.6) and a trend toward 
a 60% increased risk of cognitive impairment (OR: 1.6; CI: 0.95, 2.8) compared to those 
with normal status in both nutrients. Moreover, among those with low B12 status and high 
serum folate, the risk of anemia and cognitive impairment increased nearly five-fold (OR: 
4.8; 95% CI: 2.3, 10.4; OR: 4.9; 95% CI: 2.6, 9.2, respectively) compared to those with 
normal status in both vitamins (Morris et al., 2007).  
The authors concluded that compared to normal status for both nutrients, high 
serum folate status alone was associated with a protective effect for anemia, as well as a 
significant reduction in the prevalence of cognitive impairment. On the other hand, low 
B12 status regardless of folate status, was associated with a significantly increased risk of 
anemia and cognitive impairment. Furthermore, the combination of low B12 status and 
elevated serum folate significantly magnified the risk of both conditions (Morris et al., 
2007).  
In addition, while elevated homocysteine levels were present in the low B12 / high 
folate subjects, the prevalence of hyperhomocysteinemia (>13 µmol/L) in that group was 
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significantly lower than that of the group with low B12 status / normal folate (<13 
µmol/L) (p <0.001). Hyperhomocysteinemia primarily due to low B12 status, was 
associated with an increased risk of both anemia (OR: 2.0; 95% CI: 1.01, 3.8) and 
cognitive impairment (OR: 1.9; 95% CI: 1.1, 3.4) in this study (Morris et al., 2007).  
 
4. Factors in One-Carbon Metabolism and Health Outcomes 
a. Homocysteine and Cognitive Function 
Of unique interest, is the association between hyperhomocysteinemia and 
cognitive decline and dementia. In a prospective study looking at homocysteine levels 
and risk of dementia and Alzheimer’s disease (AD), participants (n = 1092) from the 
Framingham Heart Study were followed for eight years. Of the 111 subjects who 
developed dementia, 83 were diagnosed with AD. In the quartile-specific analysis, with 
the first quartile of Hcy concentration as the reference, the RR of AD was 1.2 (95% CI: 
0.6, 2.2) in the second quartile, 1.3 (95% CI: 0.6, 2.5) in the third quartile, and a RR of 
2.2 (95% CI: 1.2, 4.1) in the fourth quartile. In addition, plasma Hcy concentrations 
greater than 14 µmol/L, nearly doubled the risk of AD. Moreover, addition of folate, 
vitamin B12, and vitamin B6 status to the model did not significantly alter the association, 
suggesting Hcy level is a strong, independent predictor of developing AD.  
 In a recent longitudinal study, researchers investigated the associations between 
serum Hcy, vitamin B12 and folate on cognition in the elderly (Hooshmand et al., 2012). 
Measurements were taken at baseline in 274 dementia-free participants living in Finland 
in 1998. Participants were between the ages of 65 and 79 years of age at the time of entry. 
Blood samples were analyzed for total Hcy, serum folate and holoTC, as a biomarker of 
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vitamin B12 status.  In addition to the biochemical measurements, several 
neuropsychological tests were performed to assess cognitive function, including the 
Mini-Mental State Examination (MMSE), immediate word recall test, the Stroop test, 
category fluency test, and the bimanual Purdue Pegboard test. These exams provided data 
which were used to assess global cognition, episodic memory, executive function, verbal 
expression, and psychomotor speed both at baseline and at follow up.  
Hooshmand et al. (2012) found that elevated Hcy was significantly inversely 
correlated with serum folate (r= -0.42) and holoTC (r= -0.46), suggesting that high levels 
of Hcy in this study were likely indicative of low folate and low vitamin B12 status. After 
adjusting for age, sex, education, follow up time, BMI, blood pressure, smoking status, 
APOE-4, and presence of renal insufficiency, elevated Hcy was significantly associated 
with declined cognitive function in all areas assessed. With additional adjustments, the 
association between Hcy and psychomotor speed lost significance. When adjustments 
included serum folate and holoTC, the association between Hcy and MMSE score also 
lost significance.  
Elevated holoTC at baseline was significantly associated with greater 
performance in global cognition (RD = 1.08, 95% CI: 1.00, 1.17), executive function (RD 
= 1.13, 95% CI: 1.02, 1.25), and psychomotor speed (RD = 1.18, 95% CI: 1.05, 1.23) at 
follow up. When Hcy and folate were included in the model, the trend toward higher 
holoTC and improved cognitive performance remained; however, it was no longer 
significant. No significant associations between serum folate and the areas of cognitive 
function measured were identified (Hooshmand et al., 2012).  
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Strengths of this study included the population-based study design and seven-year 
follow up time, as well as the use of holoTC as a biomarker of vitamin B12 status. 
Limitations included small sample size, availability of serum samples restricted to 
baseline collection only, and the lack of other biomarkers for both vitamin B12 and folate 
status, including MMA and RBC folate.  
In a recent systematic review and meta-analysis of modifiable risk factors 
associated with cognition and dementia, investigators included 247 original 
epidemiologic studies (167 cohort studies, 80 cross-sectional studies) in their review 
(Beydoun et al., 2014). Risk factors included smoking, education, alcohol intake, 
physical activity, and Hcy, as well as nutritional factors including caffeine intake, omega-
3 fatty acids, and antioxidants. Overall, 19 cohort studies investigated Hcy and cognitive 
function. Of the 19 studies, 12 found elevated serum Hcy levels to be associated with 
poorer cognitive function and/or dementia. Two studies found an association with Hcy 
and some cognitive outcomes, but not others, and five studies were unable to detect a 
significant association with cognitive function (Beydoun et al., 2014). Homocysteine is 
said to have neurotoxic and excitotoxic properties in vitro, proposing a direct effect on 
cognitive function (Kruman et al., 2000).  
Homocysteine exposure to the primary hippocampal neurons in cultured cells 
resulted in apoptosis in a dose-dependent manner (Kruman et al., 2000). DNA strand 
breaks occurred rapidly in the neurons exposed to Hcy. Neuronal cells appeared to be 
more vulnerable to the effects of Hcy-induced apoptosis compared to other cells 
including astrocytes and cultured vascular endothelial cells. Hcy also appears to render 
neural cells more vulnerable to oxidative stress and excitotoxicity. The investigators 
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tested their hypothesis in vivo by infusing Hcy, alone and with a seizure-inducing 
excitotoxin called kainite, into the hippocampus of adult mice. While Hcy alone did not 
damage the hippocampal neurons, the combination markedly exacerbated kainite-induced 
damage to the pyramidal neurons (Kruman et al., 2000). These and other data 
demonstrating that Hcy can sensitize neurons to such adverse conditions, provide insight 
into how Hcy might contribute to the pathogenesis of neurodegenerative disorders and 
moreover suggest a possible mechanism by which nutrients involved in one-carbon 
metabolism may reduce the risk of such disorders. 
 
b. Folate and Cognitive Function 
Several studies have investigated the association of serum folate and cognitive 
decline (Duthie et al., 2002; Kado et al., 2005; Ramos et al., 2005; Ravaglia et al., 2005). 
Ramos et al. examined the association of folate status and cognitive function and 
dementia in 1789 community-dwelling elderly Latinos (Ramos et al., 2005). Multiple 
linear regression analyses were used to describe the associations between RBC folate 
concentration and cognitive function tests in four models before and after adjustment for 
serum Hcy, vitamin B12, serum creatinine, and demographics. Cognition was assessed via 
six measurements including the Modified Mini-Mental State Examination (3MSE), 
delayed recall, object naming, picture association, verbal conceptual thinking, verbal 
attention, and pattern recognition. In addition, odds ratios were evaluated as indicators of 
the relationship between RBC folate and serum Hcy as independent variables and 
diagnostic measures of cognitive decline and dementia. After adjusting for serum Hcy 
alone, RBC folate remained inversely correlated with six of the seven cognitive tests. The 
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analysis indicated that RBC folate explained 4.0–6.1% (R2 = 0.040–0.061) of the 
variance in cognition function scores within the sample. The addition of serum vitamin 
B12 and creatinine did not significantly influence the results. However, adding the 
demographic variables (age, sex, education, and acculturation) and Center for 
Epidemiological Studies Depression Scale (CES-D) score to the model significantly 
attenuated the associations. Only the 3MSE and delayed recall remained significant 
(p=0.005 and p=0.007, respectively) (Ramos et al., 2005). When evaluating RBC folate 
in the secondary analysis, the odds ratio (OR) for low 3MSE (OR = 0.51, 95% CI: 0.32, 
0.83) and dementia diagnosis (OR = 0.28, 95% CI: 0.11, 0.72) were significant after 
adjusting for all potential confounders. These data indicate that risk of cognitive 
impairment and dementia decreased with elevating concentrations of RBC folate (Ramos 
et al., 2005).  
Folic acid fortification of grains beginning in the late 1990s has significantly 
reduced the prevalence of folate deficiency in the United States (defined as plasma folate 
<6.8 nmol/L) from 22% to approximately 1.7% of the population, and the prevalence of 
hyperhomocysteinemia by almost one-half (Jacques, Selhub, Bostom, Wilson, & 
Rosenberg, 1999). Despite folic acid fortification, hyperhomocysteinemia (defined as >13 
µmol/L) is still found in approximately 9% of the U.S. population, likely due to poor B12 
status, and remains a key risk factor for adverse health outcome.  
 
c. Vitamin B12 and Cognitive Function 
Despite the association of low vitamin B12 status with hyperhomocysteinemia, and 
the later with cognitive decline, few studies have demonstrated an independent 
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association between vitamin B12 and impaired cognition. In an early study, researchers 
investigated the neuropsychiatry of megaloblastic anemia to distinguish which symptoms 
were associated with vitamin B12 deficiency versus folate deficiency (Shorvon, Carney, 
Chanarin, & Reynolds, 1980). Prior to this, no comprehensive study had been performed 
on the neuropsychiatry of vitamin B12 deficiency since the early 1950s. Shorvon et al. 
compared the neurological and psychiatric states of 84 patients admitted to a local 
London hospital. Inclusion criteria included megaloblastic anemia associated with a 
serum vitamin B12 of less than 150 ng/L (110.7 pmol/L) or a serum folate below 2.5 µg/L 
(5.7 nmol/L) together with an RBC folate level below 150 µg/L. Patients with evidence 
of both deficiencies, and/or diseases known to impact the metabolism of these nutrients 
were excluded from the study. Seventy-seven of the 84 patients underwent an 
electrophysiological study to identify peripheral nerve function (Shorvon et al., 1980).     
Fifty patients (59%) were diagnosed with vitamin B12 deficiency and 34 (41%) 
had confirmed folate deficiency. The ratio of males to females in each group was similar, 
although the mean age was higher in the vitamin B12 deficient group (mean age: 60 years) 
compared to the folate deficient group (mean age: 40 years). Of the 50 patients with 
vitamin B12 deficiency, 32 had pernicious anemia. Hematological data showed no 
significant differences between the two groups with respect to hemoglobin and mean cell 
volume (MCV). Approximately two-thirds of both groups had some form of 
neuropsychiatric abnormality. Among the vitamin B12 deficient group, 20 patients (40%) 
had peripheral neuropathy compared to only 6 patients (18%) of the folate deficient 
group. In addition, eight patients with vitamin B12 deficiency had subacute combined 
cord degeneration. This condition affects the spinal column, brain and peripheral nerves 
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first, by damage to the myelin sheath, and later, damage to the nerve cell itself. 
Symptoms can include paresthesia, unsteady gait, depression, visual changes, and 
changes in mental status, including cognitive decline and dementia. There were no cases 
of subacute combined cord degeneration in the folate deficient group.        
Further findings showed 28 patients (65%) with vitamin B12 deficiency 
demonstrated peripheral nerve disease based on electrical evidence, while only 6 patients 
(21%) with folate deficiency reported the abnormal outcomes. The authors reported that 
the clinical and electrical evidence suggests that neuropathy is approximately three times 
more common in vitamin B12 deficiency than in folate deficiency. While this study was 
not designed to detect changes in cognitive decline, it alludes to the potential, particularly 
with subacute combined cord degeneration observed only in the patients with vitamin B12 
deficiency (Shorvon et al., 1980).  
In a randomized placebo-controlled study, researchers investigated the effects of 
B-vitamin supplementation on Alzheimer’s disease (AD) related gray matter atrophy over 
a two-year period in 156 elderly participants (Douaud et al., 2013). Eighty subjects (mean 
age 77 years) received the B-vitamin mixture (0.8 mg/d of folic acid, 0.5 mg/d of vitamin 
B12, 20 mg/d of vitamin B6) and 76 subjects (mean age 76 years) received a placebo. 
There were no significant differences in demographics, cognitive function, or biomarkers 
measured at baseline between the two groups.  
Local gray matter volume was assessed at baseline and again after 2 years via 
MRI scan. Atrophy was found in similar areas in both groups; however, the group 
receiving the B-vitamins showed a significant reduction of atrophy in the posterior 
regions of the brain, those most affected by AD (Douaud et al., 2013). 
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The average reduction of gray matter 
over the two-year period was 3.7% 
(±3.7) in the placebo group and 0.5% 
(±2.9) in the B-vitamin group. Figure 
1 shows the loss of gray matter 
volume (shown in yellow) for both 
groups. The amount of yellow 
corresponds to the volume of loss.  
To investigate the effect of serum Hcy on gray matter decline with and without 
treatment, the researchers dichotomized each group by serum Hcy level (those above and 
those below the median of 11.06 µmol/L). Within the placebo group, participants with 
higher serum Hcy had more gray matter atrophy compared to those with lower Hcy 
concentrations. In the treatment group, the researchers found no difference in atrophy 
between the two Hcy groups. When testing the effect of B-vitamin supplementation on 
overall atrophy, the authors found no effect of the treatment in participants with low 
baseline serum Hcy levels. In the higher serum Hcy group however, B-vitamin 
supplementation had a protective effect on gray matter loss. Those with high serum Hcy 
showed reduced gray matter atrophy after two years of B-vitamin treatment. The average 
loss of gray matter over a two-year period for those with high serum Hcy in the placebo 
group (n=35) was 5.2% (± 3.4) compared to those with high serum Hcy in the B-vitamin 
group (n=42) who showed an average loss of 0.6% (± 2.1) (Douaud et al., 2013).  
The researchers state that the reduced atrophy in regions of the brain susceptible 
to AD appeared to be mediated by lowering of serum Hcy levels. Furthermore, while the 
Fig 1: Regional loss of gray matter volume. Douaud et al., 2013 
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B-vitamin treatment led to a change in plasma vitamin B12 and plasma folate 
concentrations, it was only plasma vitamin B12 that appeared to play a role in modifying 
Hcy levels. The lack of influence of serum folate may be due to the fact these participants 
had good folate status (mean folate 29 nmol/L) at baseline. No participant was found to 
be vitamin B12-deficient (based on the cutoff level of <150 ng/L). Nonetheless, changes 
in gray matter atrophy were significantly associated with a change in plasma vitamin B12 
levels. Elevated serum Hcy is an inhibitor of both methylation reactions and the 
proliferation of neuronal cell precursors. Vitamin B12 is responsible for methylation in the 
brain, and its deficiency can disrupt neuronal cell proliferation. Thus, it is plausible that 
vitamin B12 is essential in maintaining adult neurogenesis in the regions of the brain 
affected by AD (Douaud et al., 2013).   
 
d. Vitamin B12 and Type 2 Diabetes 
Neuropathic manifestations from microvascular complications are highly 
associated with diabetes. Vitamin B12 deficiency can exacerbate existing neuropathic 
conditions in people with type 2 diabetes (T2DM) (Adaikalakoteswari et al., 2014). 
Metformin, a class of insulin sensitizing drugs called biguanides, is the most commonly 
prescribed oral hypoglycemic agent in patients with T2DM (Liu et al., 2009). Use of 
metformin is well known to impede the absorption of vitamin B12 resulting in a 
deficiency; however, it is often overlooked and seldom investigated. Researchers sought 
to define the prevalence of vitamin B12 deficiency in a T2DM population within a 
military primary care practice (Pflipsen et al., 2009). Men and women (n=195) 45 years 
of age and older, with a diagnosis of T2DM were included in the study. Vitamin B12 
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deficiency was defined as a plasma B12 level <100 pg/mL (<74 pmol/L), or a plasma B12 
level of 100-350 pg/mL (74 – 258 pmol/L) with a corresponding methylmalonic acid 
(MMA) level >243 nmol/L and/or a homocysteine (Hcy) level >11.9 nmol/L. Inclusion 
of alternative biomarkers of B12 status have been shown to improve the sensitivity and 
specificity of detecting a deficiency and may help to identify early, asymptomatic cases 
of B12 deficiency before irreversible neurological damage. Only 60% of those with 
vitamin B12 deficiency have clinical manifestations of macrocytic anemia; thus, 
additional diagnostic measures are essential (Stabler, 2013).  
Serum vitamin B12 levels ranged from 91 to 2818 pg/mL (67 to 2079 pmol/L). 
Only one subject was deficient based solely on serum B12 <100 pg/mL, while 79 had 
insufficient levels of serum vitamin B12 of 100-350 pg/mL (74 – 258 pmol/L), 43 
proceeded to have either elevated MMA (>244 nmol/L) and/or elevated serum Hcy levels 
(>11.9 nmol/L) indicating vitamin B12 deficiency. In total 44 participants (22%) with 
T2DM were B12 deficient. Patients with B12 deficiency had T2DM significantly longer 
than those who were B12 sufficient (Pflipsen et al., 2009). When a subsequent analysis 
was conducted defining all participants with serum B12 levels <350 pg/mL (<258 
pmol/L), patients using metformin were at significantly greater risk of B12 deficiency. 
While patients taking metformin had a significantly lower B12 status compared to patients 
not taking the medication (425.99 pg/mL and 527.49 pg/mL, respectively), metformin 
use was not significantly associated with B12 deficiency. The authors stated that their 
inclusion of diagnostic criteria other than serum B12 levels (MMA and Hcy) in defining 
B12 deficiency likely improved the diagnosis of the condition. However, at the time there 
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were no published studies examining the prevalence of B12 deficiency utilizing the more 
sensitive and specific diagnostic markers in the general population.  
While this study was innovative, it contained some limitations. The cohort was 
from a military family medicine center that was deemed to be exceptional in the chronic 
care of diabetes. Thus, most participants were considered to have well-controlled T2DM, 
which may not be generalizable to the rest of the population. In addition, this study did 
not investigate the clinical manifestations of B12 deficiency such as megaloblastic 
anemia. Analyses of mean corpuscular volume (MCV), red cell distribution width 
(RDW) and/or hemoglobin and hematocrit (H/H) may have been advantageous in further 
defining clinical outcomes. Furthermore, the cross-sectional design does not allow for 
causality; however, the aim of the study was to define vitamin B12 deficiency in a diabetic 
population, for which the design was appropriate.    
Data from the 1999-2006 National Health and Nutrition Examination Survey 
(NHANES) were published on the association of vitamin B12 deficiency in US adults ≥50 
years with (n=1,621) and without (n=6,867) T2DM and with and without metformin 
usage (Reinstatler, Qi, Williamson, Garn, & Oakley, 2012). The authors defined 
biochemical vitamin B12 deficiency as serum levels ≤148 pmol/L, borderline deficiency 
as >148 to ≤221 pmol/L, and normal as >221 pmol/L. Exclusion criteria included 
pregnancy, HIV+ status, B12 injection therapy, prediabetes, and elevated creatinine levels, 
but included participants with existing liver and/or renal conditions. The authors 
examined B12 supplement use, acid blockers, homocysteine levels, MCV, hemoglobin 
A1c %, and serum folate among participants with and without T2DM. The variables were 
then stratified by metformin use (yes, n=575; no, n=1,046) within the T2DM group. Of 
46 
 
interest, serum vitamin B12 was significantly lower in participants with T2DM taking 
metformin compared to those with T2DM not taking the medication (p=0.0116), as well 
as to non-diabetics (p=0.011). The weighted prevalence of vitamin B12 deficiency 
adjusted for age, race, and gender was 5.8% for those with T2DM taking metformin, and 
2.2% not taking metformin, and 3.3% in those without T2DM. The investigators applied 
the Fleiss formula for attributable risk in cross-sectional data and found that among all 
cases of vitamin B12 deficiency, 3.5% were attributable to metformin use. Among those 
with T2DM, 41% of the vitamin B12 deficient cases were attributable to the medication 
usage. Although serum homocysteine levels were investigated, no significant differences 
were found (Reinstatler et al., 2012).      
Interestingly, the researchers noted that despite the observed effects of metformin 
use on vitamin B12 status, the overall deficiency percentage may not indicate a public 
health concern. The authors also intentionally did not include MMA as an indicator of 
vitamin B12 status. They concluded that the use of MMA and other functional measures 
of vitamin B12 status remains controversial. However, findings from a roundtable 
discussion on measurement of vitamin B12 status biomarkers in NHANES data revealed 
that measuring a circulating biomarker such as serum vitamin B12 or holoTC and a 
functional biomarker such as MMA or Hcy is preferable to measuring only one 
biomarker in NHANES (Yetley et al., 2011). In addition, the panel concluded that if 
NHANES reinstates measurement of vitamin B12 status in the future, the biomarkers will 
be serum vitamin B12 and plasma MMA.  
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5. Folate, Vitamin B12 and Telomere Length 
As two important factors in one-carbon metabolism, vitamin B12 and folate status 
vary in their association with telomere length. In most reports, vitamin B12 has shown to 
have no association with telomere length, while studies investigating a relationship 
between folate levels and telomere length appear to be more complex. One study looked 
at the association between folate status and the 677C>T polymorphism of the MTHFR 
gene and telomere length (Paul et al., 2009). The authors controlled for vitamin B12 in 
their analyses, but also reported that plasma vitamin B12 concentration was not associated 
with telomere length in their population of 195 healthy men. Interestingly, the authors 
reported a U-shaped relationship between plasma folate status and telomere length, with 
longer telomeres associated with both low and high folate status. The investigators 
reported that as plasma folate concentration moved toward the median (11.6 nmol/L), 
there was a trend toward a corresponding decrease in mean telomere length. In those with 
folate concentrations below the median, there was a corresponding increase in telomere 
length. Thus, the relative telomere length of men in the lowest quartile of plasma folate 
concentration tended to be higher than the telomere length of men in the highest quartile 
of plasma folate concentration (p = 0.11). The authors suggested that longer relative 
telomere length observed among those with very low folate status may be a result of 
telomeric dysregulation due to hypomethylation of DNA (Paul et al., 2009).    
This finding was supported by a study utilizing an in vitro model of chronic folate 
deficiency (Bull et al., 2014). Cells were grown under three simulated conditions: 
deficient, replete, and/or supraphysiological. The folate-deficient cells had a significantly 
longer mean telomere length at day 7 and 14 compared to the other two cell conditions at 
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the same time points (p=0.02). However, the mean telomere length dropped sharply after 
day 14 to below that of the other two cell conditions by day 42, indicating an increase in 
telomere length with the beginning of folate deficiency (days 7–14), followed by a 
shortening of telomere length with chronic deficiency (days >14).  
In a previous study, the authors investigated the relationship of plasma folate, 
homocysteine, vitamin B12 and RBC folate to telomere length in a fairly homogeneous 
population of 90 predominantly Caucasian, healthy men and women (Bull, O’Callaghan, 
Mayrhofer, & Fenech, 2009). In a dichotomous grouping of younger (18-32 years) and 
older (65-83 years) participants, the authors reported the mean plasma folate and RBC 
folate concentrations were significantly higher in the older subjects compared to the 
younger cohort (p = 0.0001 for both); however, no correlations were observed between 
plasma and/or RBC folate and telomere length, nor with plasma vitamin B12 and telomere 
length in this study. In addition, no differences were observed in the plasma vitamin B12 
concentrations between the two cohorts. Of note, this study was limited in sample size 
and likely lacked sufficient power to detect a significant finding if indeed one existed 
(Bull et al., 2009).  
Despite the above findings, current research suggests vitamin B12 deficiency is 
more common in older adults. Vitamin B12 deficiency ranges from 5–40% (depending on 
the definition used) resulting from inadequate vitamin B12 intake and more commonly, 
impaired absorption (Wong, 2015). According to NHANES data, the prevalence of 
vitamin B12 deficiency (serum B12 <148 pmol/L) among those 20–39 years of age was 
<3%, and close to 4% for those aged 40–69 years (Allen, 2008). For individuals over 70 
years, the prevalence was double that of the younger group at 6%. Among those 
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considered to be marginally deficient (serum B12 of 148–221 pmol/L), the percentage 
increased to 14%–16% in those aged 20–59, to over 20% in those over 60 years old. In 
other parts of the world, prevalence of deficient or marginal vitamin B12 status among 
children and adults can range from 40% in Latin America to as high as 70% - 80% in 
Africa and India, respectively (Allen, 2008).  
In a seminal publication by Liu et al. investigating factors of one-carbon 
metabolism from the Nurses’ Health Study (NHS), the authors reported no associations 
between plasma folate (P-trend = 0.90), plasma vitamin B12 (P-trend = 0.94), plasma vitamin 
B6 (PLP) (P-trend = 0.78), and plasma homocysteine levels (P-trend = 0.57) and relative 
telomere length in a total of 1,624 participants, after adjusting for age, smoking, body 
mass index (BMI), and physical activity (Liu et al., 2013). Higher plasma cysteine levels 
were significantly associated with shorter relative telomere length in this population (P-
trend = 0.02). Furthermore, the authors reported no significant associations found among 
the dietary intakes of folate (P-trend = 0.94), vitamin B12 (P-trend = 0.55), and vitamin B6 (P-
trend = 0.71) and quartiles of relative telomere length after adjusting for the potential 
confounders (J. J. Liu et al., 2013).       
The authors noted that this was the only study investigating all factors of one-
carbon metabolism on telomere length. While this study demonstrated strength in sample 
size and use of physiological biomarkers of vitamin B12 and folate, it has some 
limitations. The study was cross-sectional by design, which negates the ability to make 
causal inference. In addition, the study was conducted predominately in white women. It 
remains possible an association exists in men or in different racial/ethnic groups. Finally, 
the only representation of vitamin B12 and folate status were plasma levels of the 
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vitamins. The authors did not investigate MMA as a biomarker of vitamin B12 status 
which has been reported in literature to be superior to plasma vitamin B12 levels in 
defining total body status. Additionally, the authors did not investigate RBC folate, which 
has been suggested to be a better representation of current folate status.  
Data from the Framingham Offspring Cohort (1991-1995 and 1995-1998) yielded 
an association between plasma folate levels post-folic acid fortification and telomere 
length (Paul et al., 2014). The authors controlled for covariates including age, sex, BMI, 
smoking, alcohol intake, serum creatinine, and menopause status in 1,044 men and 
women. General linear regression models were used to determine the association between 
telomere length and plasma folate in quintiles, as well as for folic acid fortification and 
supplement use. The mean telomere length of those participants examined before folic 
acid fortification was 6.95 kb (±0.04), while individuals examined post-fortification had a 
mean telomere length of 6.88 kb (±0.04) (p = 0.14) (Paul et al., 2014). When plasma 
folate concentrations were divided into quantiles, those in the fifth quintile (highest 20% 
of serum folate levels) had a significantly shorter mean telomere (-180 bp) length 
compared to those in the second quintile (p < 0.01) (Paul et al., 2014). While not 
significant, individuals in the first quintile of plasma folate had a shorter mean telomere 
length compared to those in the second quintile, revealing a non-linear, bell-shaped 
relationship. These data coincide with previous literature supporting the relationship 
between folate and markers of health status. Low plasma folate is associated with DNA 
hypomethylation and telomere length is determined by DNA integrity. Loss of DNA and 
histone methylation, for which folate plays a major role, results in a dysregulation, 
yielding unusually long, dysfunctional telomeres in cell culture (Bull et al., 2014). Thus, 
51 
 
low, as well as elevated plasma folate, can impair DNA synthesis and adversely affect 
telomere length. Extreme plasma folate concentrations have been associated with poorer 
health outcomes, and in this study, a shorter mean telomere length (Ericson et al., 2010; 
Paul et al., 2009).  
Data were collected both pre- and post-folate fortification. While the mean 
telomere length of participants was shorter post-fortification, the difference was not 
significant (Paul et al., 2014). The investigators also looked at supplement usage. 
Multivitamin (MVI) users had a significantly shorter telomere length compared to non-
users (p = 0.015). This finding contrasts with that of Xu et al., who found a positive 
correlation between MVI use and telomere length (Xu et al., 2009). Interestingly, 83% of 
those in the fifth quintile of plasma folate (shortest telomere length) were multivitamin 
users.  Increasing plasma folate concentration was associated with a shorter mean 
telomere length (second through fifth quintiles) even after multivitamin users were 
removed from the analysis (Ptrend<0.01). Additionally, while plasma folate concentration 
was negatively associated with plasma homocysteine levels (r= -0.2426, p< 0.0001), the 
investigators found no association between serum vitamin B12 and/or serum pyridoxal 
5’phosphate (PLP) and telomere length (Paul et al., 2014). 
Although the study by Xu et al. (2009) found an association between elevated 
plasma folate and shorter telomere length, other studies have found a positive relationship 
between the two variables. In a population-based cohort, investigators measured 
homocysteine and serum folate levels in 1,319 healthy subjects (91.5% women) 
(Richards et al., 2008). The authors reported higher serum folate levels were associated 
with an increase in age-adjusted telomere length (β = 0.01, 95% CI: 0.004-0.017) 
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(Richards et al., 2008). Homocysteine levels were found to be inversely correlated with 
telomere length after adjusting for age, C-reactive protein (CRP) levels, physical activity, 
and glomerular filtration rate (GFR) (Ptrend=0.007). When serum folate was dichotomized 
(high and low) within tertiles of homocysteine concentration, the difference in telomere 
length between the high folate group within the lowest tertile of homocysteine and the 
low folate group within the highest tertile of homocysteine was 159 bp (95% CI: 64 -255; 
p = 0.001). According to the researchers, this is equivalent to 8.6 years of biological 
aging. Within each tertile of homocysteine, individuals with higher serum folate levels 
had a longer mean telomere length (Ptrend =0.002).  
Similarly, researchers found that higher plasma folate status in older men was 
associated with longer telomere length (p = 0.04) (Bull et al., 2009). However, this 
association was not observed in older women, or in the younger cohort. The authors also 
reported a significant association between higher homocysteine levels and shorter 
telomere length in older men (p = 0.004).  Likewise, Rane et al. found a significant 
association between elevated Hcy levels and shorter telomere length in their study of 100 
adult men and women randomly selected from a prospective population-based cohort of 
63,257 Chinese citizens (Ptrend = 0.014) (Rane et al., 2015). While mean telomere length 
was longest among those in the highest tertile for folate concentration, the association did 
not reach statistical significance.  
D. Summary 
As one of the common hallmarks of aging, telomere attrition is associated with 
morbidity and mortality. Use of telomere length as a biomarker of health and aging is 
gaining credence in epidemiological studies. Shorter telomeres have been associated with 
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many chronic health outcomes such as cardiovascular disease, Alzheimer’s disease, 
cancer, and diabetes. Furthermore, telomere length has also been shown to be an 
independent risk factor and predictor for insulin resistance, type 2 diabetes, as well as 
cardiovascular disease related events including myocardial infarction and stroke.  
Micronutrients are vital components for proper body functioning; however, in 
excess, these essential compounds can be detrimental toward optimal health.  To date, 
evidence of a causal relationship between poor iron status and/or factors of one-carbon 
metabolism and telomere length remains elusive. Of the studies performed, many have 
been potentially underpowered, or lacked sufficient biomarkers for proper categorization 
of exposure variables.  
The relationship between folate and telomere length thus remains controversial, 
with evidence of both non-linear, linear, and no associations found (Bull et al., 2009; Paul 
et al., 2009, 2014; Richards et al., 2008). It remains unclear as to whether there is an ideal 
folate status at which telomere length is optimal. Furthermore, while no studies have 
demonstrated a direct association with vitamin B12 status and telomere length, to our 
knowledge, they have not used MMA as an additional biomarker of vitamin B12 status. 
Evidence suggests vitamin B12 and folate play key roles in factors that may influence 
telomere length; thus, further investigation on factors of one-carbon metabolism would 
fill a much-needed gap in the literature.  
To our knowledge, no studies have published data on iron deficiency and 
telomere length; thus, it is unclear whether low iron status or iron deficiency is associated 
with telomere length. As a public health concern, iron deficiency is the most common 
nutritional deficiency worldwide and leading cause of anemia in the United States (World 
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Health Organization, 2001). Although two studies have alluded to the negative effect of 
high iron status (hemochromatosis) on telomere length (Mainous III et al., 2013, 2014), 
larger studies in diverse populations are lacking. Hence, research on overall iron status 
and telomere length is warranted.  
 
E. Objective 
The objective of this research project is to investigate the impact of micronutrient 
status on telomere length. Our central hypothesis is that altered micronutrient status (i.e. 
low vitamin B12 status, suboptimal and/or elevated folate status, suboptimal and/or 
elevated iron status) will be associated with a shorter mean telomere length when 
compared to those with sufficient status of the corresponding micronutrients. There is 
plausible evidence to suggest the use of telomere length as a biomarker for predicting 
disease risk and mortality. Our rationale for undertaking this research is that by 
identifying modifiable nutritional risks associated with shorter telomere length, we may 
be able to positively impact biological aging and disease risk by correcting the impaired 
micronutrient status of vulnerable individuals.  
1. Papers #1 and #2: Impaired Levels of Select Factors of One-Carbon Metabolism 
are Associated with a Shorter Mean Telomere Length in Adult Men and Women. 
Our working hypothesis for this aim is that suboptimal vitamin B12 and folate status are 
associated with a shorter mean telomere length in adult men and women, independent of 
one another. Our experimental approach will be to investigate the association between 
vitamin B12 and folate status, determined by serum vitamin B12 concentration and 
methylmalonic acid (MMA) level for B12 status and serum folate concentration for folate 
55 
 
status, and mean telomere length in base pairs to determine the extent to which 
suboptimal vitamin B12 status and/or suboptimal or elevated folate status are 
independently associated with telomere length, in a nationally representative sample of 
adult men and women in the United States.  
a. Specific Aim: Factors of One-Carbon Metabolism Status and Telomere Length 
To evaluate the association of vitamin B12 and folate status on telomere length in 
a nationally representative sample of adult men and women.  
Hypothesis 1a: Compared to participants with adequate vitamin B12 status, men and 
women with suboptimal vitamin B12 status will have a shorter mean telomere length after 
controlling for relevant covariates including folate status. 
Hypothesis 1b: Compared to participants with adequate folate status, men and women 
with deficient, as well as elevated plasma folate, will have a shorter mean telomere length 
after controlling for relevant covariates including B12 status. 
Hypothesis 1c: Compared to subjects with sufficient vitamin B12 and folate status, men 
and women with suboptimal vitamin B12 status and elevated folate status will have a 
shorter mean telomere length after controlling for relevant covariates. 
Gap in Knowledge: Previous studies investigating micronutrient status have reported 
inconclusive results. Studies investigating vitamin B12 have found no association between 
serum B12 or low vitamin B12 intake and telomere length. One study did find an 
association with use of vitamin B12 supplements and a longer mean telomere length.  
To our knowledge, no study has explored the association of suboptimal vitamin 
B12 status (defined by serum vitamin B12 and MMA concentrations) and telomere length 
in a nationally representative, population-based sample. In addition, investigations of 
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folate status and telomere length have yielded varying results, and the association appears 
to be complex. Research has demonstrated a non-linear, bell-shaped relationship between 
plasma folate and mean telomere length, as well as a linear relationship between the two 
variables. Given the interwoven relationship between folate and vitamin B12 with regards 
to metabolism and nutrient status, the two micronutrients should be investigated 
concurrently.  
4. Paper #2: Impaired Iron Status is Associated with Shorter  
Telomere Length in Adult Men and Women. 
 
Our working hypothesis for this aim is that low iron status (iron-deficiency anemia and 
iron deficiency) as well as elevated iron status, are associated with a shorter mean 
telomere length in adult men and women. Our experimental approach will be to 
investigate the association between iron status, determined by serum iron concentration, 
serum ferritin, transferrin saturation percent, erythrocyte protoporphyrin level, and 
hemoglobin concentration, and mean telomere length to determine the extent to which 
suboptimal iron status is associated with telomere length in a nationally representative 
sample of adult men and women. 
a. Specific Aim: Iron Status and Telomere Length 
To evaluate the association of iron status on telomere length in a nationally 
representative sample of adult men and women.  
Hypothesis 2a: Compared to subjects with adequate iron status, men and women with low 
iron status will have a shorter mean telomere length after controlling for relevant 
covariates. 
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Hypothesis 2b: Compared to subjects with adequate iron status, men and women with an 
elevated iron status will have a shorter mean telomere length after controlling for relevant 
covariates. 
Gap in Knowledge:  To our knowledge, no study has investigated the impact of iron 
deficiency on telomere length in adult men and women. Few studies have examined the 
role of elevated iron status on telomere length in adults. Of the studies conducted, 
research has focused on transferrin saturation and genetic markers of hemochromatosis as 
indicators of iron status. Furthermore, the use of multiple biomarkers of iron status 
including serum iron, ferritin levels, transferrin saturation percentage (TS%), erythrocyte 
protoporphyrin, and hemoglobin levels, will provide additional criteria for determining 
iron deficiency as well as that of elevated iron status or iron overload.  
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CHAPTER 2 
 
FACTORS OF ONE-CARBON METABOLISM AND  
TELOMERE LENGTH IN ADULT MEN AND WOMEN  
A. Introduction 
 Telomeres are repetitive, non-coding nucleotide sequences at the end of all 
vertebrate chromosomes (TTAGGG in humans) first recognized by Muller and 
McClintock in 1938 and 1941, respectively through their work with Drosophila 
(McClintock, 1941). Telomeres function as protective caps on the chromosomes and play 
an indispensable role in DNA replication and stability. Credit for this discovery went to 
Blackburn, Greider, and Szostak, who were awarded the Nobel Prize in Physiology or 
Medicine in 2009. The guanine-rich 3’ projection of the telomere is thought to be of 
particular importance; acting as a buffer to protect gene coding sequences enabling gene 
continuity through DNA replication (Greider, 1998). However, the guanine residues of 
telomeres also  make them highly susceptibility to damage caused by oxidative stress 
(Houben, Moonen, van Schooten, & Hageman, 2008; Matthews et al., 2006; Von 
Zglinicki, 2002).  
Telomere attrition has become a widely accepted cellular event associated with 
aging. Additionally, telomeric loss and dysfunction have been associated with chronic 
conditions such as cardiovascular disease (Fitzpatrick et al., 2007), hypertension (Samani 
et al., 2001), type 2 diabetes, (Verhulst et al., 2016; Willeit et al., 2014; Zhao et al., 2014)  
Alzheimer’s disease (Panossian et al., 2003), and certain cancers (Du et al., 2015; Willeit 
et al., 2010) independent of chronological age. Thus, telomere length assessment holds 
potential as a biomarker of risk assessment for adverse health outcomes.   
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It is well known that dietary factors can influence the risk of chronic disease, but 
the mechanisms of action by which micronutrient status influences chronic disease 
outcomes are complex and, in most cases, uncertain. Antioxidants can quench reactive 
oxygen species (ROS) resulting from oxidative stress, and thus may provide protection to 
susceptible telomeres. Several studies have demonstrated a positive relationship between 
dietary antioxidant intake and telomere length (Boccardi et al., 2013; García-Calzón, 
Zalba, et al., 2015; Marcon et al., 2012; Mazidi, Kengne, & Banach, 2017), as well as 
antioxidant supplementation (Xu et al., 2009). Factors affecting one-carbon metabolism 
could also influence telomere length; however, findings from studies investigating intake 
of nutrients involved in this pathway have been inconsistent (Liu et al., 2013).  
Folate and vitamin B12 are two important B-vitamins involved in one-carbon 
metabolism. Xu et al. (2009) reported a longer mean telomere length associated with 
women who consumed vitamin B12 supplements compared to non-users, although 
vitamin B12 status was not measured. In most studies, plasma vitamin B12 concentration 
has not been associated with telomere length, and the association between plasma folate 
and telomere length has been inconsistent (Bull et al., 2009; Liu et al., 2013; Paul et al., 
2014). In previous studies involving telomere length, B12 status had been identified using 
serum vitamin B12 level as the sole indicator; while the association between plasma folate 
concentration and telomere length has been reported to be  a U-shaped relationship (Paul 
et al., 2009), a bell-shaped relationship (Paul et al., 2014), as well as having no 
association (Liu et al., 2013).  
Of recent interest are reports of the apparent negative interactions between 
elevated folate intakes in participants and low B12 status on various health outcomes 
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(Morris et al., 2007; Morris, Selhub, & Jacques, 2012). Using the NHANES database, 
researchers investigated the cross-sectional association between serum folate and vitamin 
B12 status relative to macrocytic anemia and cognitive impairment among 1,459 elderly 
participants. After controlling for potential confounders, low B12 status (<148 pmol/L 
and/or MMA >210 nmol/L) was associated with increased risk of anemia (OR 2.7; 95% 
CI 1.7, 4.2), macrocytic anemia (OR 1.8; 95% CI 1.01, 3.3), and cognitive impairment 
(OR 2.5; 95% CI 1.6, 3.8) (Morris et al., 2007). Additionally, those with low B12 status 
and elevated serum folate (>59 nmol/L) had a greater risk of anemia (OR 3.1; 95% CI 
1.5, 6.6) and cognitive impairment (OR 2.6; 95% CI 1.1, 6.1) (Morris et al., 2007). 
Explicitly, anemia and cognitive impairment were observed nearly five-times as often in 
this group, compared to the group with normal status in both vitamins. In contrast, 
normal vitamin B12 status (>256 pmol/L) coupled with high folate, provided protection 
against cognitive impairment (OR 0.4; 95% CI 0.2, 0.9) (Morris et al., 2007).  
In a longitudinal study, the same authors further investigated B12 and folate status 
and cognition in 549 participants using the prospective Framingham Heart Study (FHS) 
and the Mini-Mental State Examination with an 8-year follow up (Morris et al., 2012). 
Vitamin B12 and folate status were assessed in quintiles. The average rate of cognitive 
decline was 0.24 points/year. There was a significantly faster rate of cognitive decline 
(0.35 points/year) reported among participants in the lowest two quintiles (< 256.8 
pmol/L) compared to the upper three-fifths (≥ 256.8 pmol/L) of vitamin B12 status. With 
folate, the lowest two quintiles and the upper most quintile had similar and faster rates of 
cognitive decline, compared to the third and fourth quintiles. This parallels data on folate 
status and telomere length in which the lowest and highest concentrations of folate have 
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negative outcomes. Furthermore, in the presence of  low B12 status, high plasma folate (≥ 
20.2 nmol/L) exacerbated the rate of cognitive decline to approximately 1-point per year 
(Morris et al., 2012). To date, no study has investigated the possible interaction of 
vitamin B12 and folate status on telomere length.  
B. Material and Methods 
1. Study Population 
Data from the National Health and Nutrition Examination Survey (NHANES) 
cycles 1999-2000 and 2001-2002 were used in our analyses because telomere length has 
only been measured in these two cycles. The NHANES is conducted by the National 
Center for Health Statistics (NCHS), which is part of the Centers for Disease Control and 
Prevention (CDC) and is responsible for publishing health statistics on a nationally 
representative sample of the US population. The NHANES survey data include 
information on demographic, socioeconomic, dietary, and health-related questions, as 
well as a laboratory and physical examination component. Participants are selected using 
a multistage cluster sampling design with oversampling occurring for persons aged 60 
and older, African Americans, and Hispanics.  
Eligible participants included men and women aged 20 years and older, who had 
blood stored for DNA analysis and subsequent mean T/S ratio data available. Of the 
original 7,827 participants with data on telomere length, 33 participants were excluded 
for missing data on the primary exposure variables (serum vitamin B12 and 
methylmalonic acid (MMA), a biomarker of vitamin B12 status). Serum vitamin B12 and 
folate concentrations may appear artificially depressed or elevated in patients with 
chronic liver or kidney disease. Renal failure is a common reason for elevated serum B12 
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levels (Patil, Bhosle, & Malik, 2016). Thus, we further excluded men and women with 
elevated serum creatinine (1.7 mg/dL (n = 81) and 1.5 mg/dl (n = 40), respectively), and 
those who answered yes to questions KIQ020 [KIQ022] (ever told you had weak/failing 
kidneys?) (n = 211), MCQ170L (do you still have a liver condition?) (n = 92), as well as 
those with elevated liver enzymes (ALT ≥125 U/L, AST ≥80 U/L, and Alkaline 
Phosphatase ≥169 U/L; three standard deviations above the mean) (n = 66). Women who 
had a positive pregnancy test (code URXPREG) were also excluded from the study (n = 
443), bringing the total loss of participants to 966. After reviewing the data for outliers 
and/or possible erroneous values via scatterplot data, participants with a telomere length 
greater than 10,000 base pairs (bp) (n=3), a serum vitamin B12 level above 10,000 pmol/L 
(n=11), and/or a serum folate level 3 SD above the mean (≥ 93.3 nmol/L) (n = 108) were 
excluded from the sample population. The final sample size consisted of 6,739 men and 
women for whom data on telomere length, vitamin B12 status, and folate status were 
available. The inclusion of all covariates (described below) in the adjusted multiple 
regression models brought the total number of participants for all analyses to 5,941.  
2. Variables 
Telomere length was our primary outcome. With each NHANES data collection 
cycle, blood samples are obtained and analyzed immediately. A small portion of the 
blood was reserved for future analysis of DNA, including telomere length. The telomere 
length assay was performed by Dr. Elizabeth Blackburn at the University of California, 
San Francisco (Cawthon, 2002). Polymerase chain reaction (PCR) methodology was used 
to measure the telomere length (T) relative to a standard reference DNA (S) producing a 
T/S ratio. Samples had been assayed in duplicate, three times on three different days, 
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resulting in 6 data points that were then averaged. The final interassay coefficient of 
variation was 6.5%. The formula reported in the NHANES database for converting T/S 
ratio to a more intuitive base pair variable is (3,274 + 2,413 * (T/S)). This formula is 
calculated based on the comparison of telomeric restriction fragment (TRF) length from 
Southern Blot analysis and T/S ratios using DNA samples from the human diploid 
fibroblast cell line IMR90 (Cawthon, 2002; Needham et al., 2013).  
The main exposure variables were vitamin B12 status, determined using both 
serum vitamin B12 and methylmalonic acid (MMA) levels, and folate status. Vitamin B12 
and folate concentration measurements were performed using Quantaphase II 
Folate/vitamin B12 radioassay kit from Bio-Rad Laboratories. Analysis of MMA 
concentration was performed by gas chromatography and a mass selective detector using 
ion monitoring.   
Based on a previous study examining vitamin B12 status and macrocytic anemia 
(Morris et al., 2007), low vitamin B12 status was defined as a serum vitamin B12 level of 
≤148 pmol/L and/or a serum MMA level of ≥210 nmol/L. This value is based on the 
upper end of the reference range for serum vitamin B12-replete participants with normal 
creatinine levels. Folate status was categorized as suboptimal, sufficient, and elevated. 
Serum folate levels were based on guidelines set forth by the World Health Organization 
on serum and red blood cell folate concentrations for assessing folate status in 
populations; the suboptimal serum folate cut-off value was set at  ≤13.4 nmol/L, and 
elevated serum folate at ≥ 45.3 nmol/L (World Health Organization, 2015). We defined 
sufficient folate status as those concentrations falling in between suboptimal and 
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elevated; thus, participants with serum folate levels greater than 13.4 nmol/L and less 
than 45.3 nmol/L were considered sufficient. 
The demographic covariates for this study included age, sex and race/ethnicity. 
Age was a continuous variable in years, sex was coded “male” or “female,” and 
race/ethnicity was coded “White/non-Hispanic,” “Mexican/Hispanic,” “Black/non-
Hispanic,” and “Other/Multi-Racial.”  
Markers of socioeconomic status included educational status and annual 
household income. Educational status consisted of “≤11th grade,” “high school graduate 
or GED equivalent,” and “some college or beyond.” Annual household income was 
determined to be non-significant in the model and was later dropped from further 
analyses.   
Smoking status was categorized as “never,” “former,” and “current” smokers. 
Current smokers were further categorized by average number of cigarettes smoked per 
day. The “never” group consisted of those participants who answered no to question 
SMQ020 (smoked at least 100 cigarettes in life?). Former smokers were those who 
answered yes to SMQ020, but no to SMQ040 (do you now smoke cigarettes?). Current 
smokers were those who answered 1 or 2 (every day or some days, respectively) to 
question SMQ040 (Do you now smoke cigarettes?). This group was further categorized 
using the answer to question SMD070 (# cigarettes smoked/day now?), into <10 
cigarettes/day, 10 to 19 cigarettes/day, and ≥20 cigarettes/day. The smoking variable was 
based on cigarette smoking only. Other methods of smoking or use of chewing tobacco 
were not assessed.  
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Alcohol intake was categorized as “never,” “former moderate,” “former heavy,” 
“current moderate,” and “current heavy.” There were 378 missing answers from 
respondents, six of whom answered “unknown” for intake on the questionnaire. Never 
drinkers were those answering no to having had at least 12 alcoholic drinks over the past 
12 months and no to having had at least 12 alcoholic drinks in a lifetime. Former drinkers 
were those who answered yes to at least 12 drinks in a lifetime, but no to having drank 
alcohol over the past 12 months. Former drinkers were divided into moderate and heavy 
intakes. Heavy drinkers answered yes to ever having ≥ five drinks every day. Current 
drinkers were also divided into moderate and heavy alcohol intake. Current moderate 
drinkers consumed an average of ≤ two drinks/day, while current heavy drinkers 
consumed ≥ three drinks/day. 
Blood glucose status was defined as normal, borderline, and diabetes using an 
algorithm of biochemical markers including percent hemoglobin A1c (%A1c), fasting and 
non-fasting plasma glucose levels, as well as medical history questionnaire data. 
Participants were categorized as having diabetes if they answered yes to taking insulin, to 
having been told they have diabetes by a doctor, and/or to taking oral glucose agents. 
Biochemical data for diabetes included a %A1c of ≥6.5, a fasting plasma glucose of ≥126 
mg/dL, a plasma glucose of ≥ 200 mg/dL, and/or a fasting glucose of ≥126 mg/dL with 
an %A1c ≥5.7, but <6.5. Participants were categorized as borderline blood glucose status 
if they answered yes to having been told they have pre-diabetes. Biochemical data for 
borderline diabetes included a %A1c ≥5.7 but <6.5% with a fasting plasma glucose ≥100 
mg/dL, but <126 mg/dL. The remaining participants were categorized as having normal 
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blood glucose status if they did not meet the above criteria for impaired glucose. Those 
lacking data on two or more of these markers were categorized as missing.  
3. Statistical Analysis 
Data analyses were performed using STATA/IC version 13.1 to test our 
hypothesis that low vitamin B12 status, as well as suboptimal and/or elevated folate status 
is associated with shorter telomere length in adult men and women.  The continuous 
variables included age, body mass index (BMI), serum vitamin B12 concentration, serum 
folate, methylmalonic acid level (MMA), C-reactive protein (CRP), and homocysteine 
levels, were reported as the unadjusted mean (±SD) by both vitamin B12 and folate status. 
Categorical variables included sex, race, educational status, smoking status, alcohol 
intake status, and blood glucose status, and were reported as counts (%) by vitamin B12 
and folate status. The age-adjusted mean telomere length was calculated for the 
categorical variables by exposure status. Statistical analyses for vitamin B12 status 
subgroups (low and sufficient) were performed using a two-sample T-test analyses. We 
used analysis of variance (ANOVA) and Chi-Squared test to examine whether covariate 
distributions differed across folate status subgroups (suboptimal, sufficient, and elevated). 
A p-value of < 0.05 was considered statistically significant for all tests. The main 
outcome and exposures had equal variances based on results of Levenes’s test for 
homoscedasticity. ANOVA analysis was used to calculate the age-adjusted mean 
telomere length for vitamin B12 and folate status subgroups, and to test for effect within 
our categorical covariates. 
We tested our main hypotheses by evaluating vitamin B12 and folate status and 
telomere length in a multiple linear regression model adjusting for potential cofounding 
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variables. The above-mentioned covariates were assessed for their effect on telomere 
length or confounding with vitamin B12 status and/or folate status. A multiple F-test was 
used to test the statistical significance of the parameters in the model. If a variable 
demonstrated no effect on the relationship between telomere length and our exposure 
variables (p>0.05) the parameter was eliminated from the model. The normality of the 
continuous variables was assessed via graphical methodology, C-reactive protein (CRP), 
body mass index (BMI) and plasma homocysteine were subsequently log-transformed to 
achieve greater homoscedasticity. We presented the telomere data as base pair units.  
We fit linear regression models of vitamin B12 status and folate status, on the 
outcome of telomere length adjusting for age alone, reported in model 1. Data are 
presented as the change in mean telomere length (bp). We used the log-transformed mean 
telomere (T/S) ratio in the linear regression analysis, prior to the calculation of bp, to 
determine the β coefficient for age. We later used this value in determining an estimate of 
biological aging associated with telomeric shortening. The regression coefficient for age 
was -0.0058 (0.6%), which corresponded to telomere length reduction of 14.1 bp per each 
one-year increase in participant age. Model 2 represents the multiple linear regression 
that included sex and race, in addition to age. We chose to conduct the analyses in stages 
due to the particularly strong correlation of age, as well as sex and race, with telomere 
length. Model 3 is the fully-adjusted model that included the above-mentioned covariates, 
as well as educational status, smoking status, alcohol intake status, BMI, blood glucose, 
serum homocysteine and CRP levels.   
Given the importance of adequate vitamin B12 status in folate metabolism, we 
created an interaction term of vitamin B12 and folate status and formally tested it within 
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the three multiple linear regression models described above. Multiple F-test analyses 
were conducted to test for significance. We included age in the interaction term given the 
significant correlation between it and our outcome. We then formally tested the 
interaction term of B12 status, folate status, and age for significance.  
We repeated the model including the interaction term of B12 and folate status with 
stratification on age to determine if there was effect modification by age and followed 
with multiple F-test analyses to test for significance. Analysis of variance (ANOVA) was 
used in determining age-adjusted mean telomere length for the subgroups of the 
interaction term and testing significance.    
 
C. Results 
1. Descriptive Data 
Table 2.1 represents descriptive data for the 5,941 men and women in the study 
population (49.2% female). The mean age was 50.1 years (±18.1). Non-Hispanic (NH) 
white participants made up 51.9% of the population, 17.4% were NH-black, 28.2% were 
Mexican/Hispanic, and 2.7% were multi-racial.  
The mean telomere length for the total population was 5737.2 (7.4) base pairs 
(bp), and for males and females it was 5706.2 (10.4) and 5769.1 (10.5), respectively. NH-
black participants had the longest mean telomere length (5844.8 bp [17.8]) of any 
racial/ethnic group, while Mexican/Hispanic participants had the shortest (5648.1 bp 
[13.9]).  
The total population age-adjusted mean (SE) for serum vitamin B12 and serum 
folate concentrations were 387.3 (3.8) pmol/L, and 32.0 (0.2) nmol/L, respectively. There 
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was an even distribution of B12 and folate status between men and women. NH-white 
participants had the highest percentage of low B12 status (19.1%), while NH-black 
participants had the lowest percentage (8.6%). A contrasting profile was found with 
folate status distribution, where NH-black participants had a higher percentage of 
suboptimal folate status (10.7%) compared to NH-white participants (5.3%). Elevated 
folate status was highest among NH-whites (23.0%) and lowest among NH-blacks 
(6.8%). Mexican/Hispanic participants fell between these percentages for both 
suboptimal and elevated folate status (6.5% and 10.2%, respectively). Approximately 
2.2% of our study population had a mean serum vitamin B12 level ≤ 148 pmol/L, and 
15.5% had low vitamin B12 status. Approximately 6.6% of the study population was 
classified as suboptimal folate status, and 16.4% were classified as elevated folate status. 
Only 1.3% of the study population had low status in both nutrients, while 2.2% had low 
vitamin B12 status coupled with elevated folate status. Table 2.2 represents the age-
adjusted mean telomere length (SE) for the interaction between vitamin B12 and folate 
status.  
 
a. Vitamin B12 Status and Telomere Length 
 Table 2.3 presents data from multiple linear regression models of vitamin B12 
status, folate status, and telomere length. In the age-adjusted model (Model 1), low 
vitamin B12 status was significantly associated with shorter telomere length (β = -56.6 bp, 
p=0.006). After adjusting for race and sex in addition to age (Model 2), the effect waned 
slightly while remaining significant (β = -46.7 bp, p=0.025). The fully-adjusted model 
included the addition of BMI, CRP and homocysteine levels, educational status, smoking 
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status, and alcohol intake (Model 3), low B12 status remained significantly associated 
with shorter telomere length (β = -55.1 bp, p=0.01).  
 
b. Folate Status and Telomere Length 
 In the age-adjusted linear regression model (Model 1), suboptimal folate status 
was negatively associated with mean telomere length (β = -67.9 bp, p=0.023) (Table 
2.3). After adjusting for race and sex (Model 2), the association strengthened slightly, and 
suboptimal folate status continued to be associated with a shorter mean telomere length 
(β = -76.1 bp, p=0.011) compared to sufficient folate status. In the fully adjusted model 
for folate status (Model 3), suboptimal folate status remained significantly associated 
with a lower mean telomere length (β = -68.9 bp, p=0.026) compared to sufficient folate 
status. No association between elevated folate status and telomere length was found in 
any regression model.  
 
c. Interaction of B12 and Folate Status and Telomere Length 
 The interaction of B12 status and folate status was evaluated in the fully adjusted 
model. The F-test yielded borderline significance (p = 0.16). When age was included in 
the interaction of B12 and folate, the F-test was nearly significant at p = 0.06.  
 
d. Interaction of B12 and Folate Status and Telomere Length Stratified by Age 
 Table 2.4 represents data from the interaction of B12 and folate status in the fully-
adjusted multiple linear regression model, stratified by age categories of 20 – 39 years, 40 
– 59 years, and >60 years. The F-tests testing the interaction between B12 and folate 
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status, after stratifying by age, yielded p-values of 0.43, 0.02, and 0.23, respectively. 
There was a significant interaction between vitamin B12, folate, and age within those 40 – 
59 years, or middle-aged. Specifically, among middle-aged adults, low B12/elevated 
folate status was significantly associated with a shorter mean telomere length (β = -382.5 
bp, p=0.007) compared to those sufficient in both nutrients of the same age group. A 
significantly longer mean telomere length was observed in those with sufficient B12 and 
elevated folate in the same age group (β = 111.0 bp, p=0.009). This association was not 
present in the other age groups. No interaction associations were found in those over 60 
years of age.  
 
D. Discussion 
We observed an interaction among B12 status, folate status and age and telomere 
length in adult men and women. Specifically, we found that low B12 status in the 
presence of elevated folate level was significantly associated with a shorter mean 
telomere length in middle-aged adult men and women.  
Few studies have investigated the role of one-carbon metabolism factors on 
telomere length. Of the studies conducted, none have reported an association with 
vitamin B12 status and telomere length, while the relationship with folate status and 
telomere length has demonstrated varied results (Liu et al., 2013; Paul et al., 2009, 2014). 
To our knowledge, no studies have defined B12 status utilizing serum vitamin B12 along 
with MMA levels as we have, with the aim of investigating its association with telomere 
length in the presence of elevated folate.  
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Several studies have demonstrated negative health outcomes associated with 
elevated folate levels in the presence of low B12 status (Brito et al., 2016; Deng, Wang, 
Wang, & Kwok, 2017; Morris et al., 2005; Morris et al., 2007, 2012; Selhub, Morris, & 
Jacques, 2007). We found that in middle-aged participants with low B12 status, the 
presence of elevated folate levels may be detrimental to telomere length. Given the β 
coefficient for age in our simple linear regression model yielded an estimate of 14.1 bp 
telomeric attrition per each one-year increase in participant age, we used this coefficient 
to predict the amount of biological aging in those with low vitamin B12 and elevated 
folate levels. The advanced telomeric attrition of 382 bp in this group can be interpreted 
as an additional 27 years of biological aging. In other words, among middle-aged adults, 
those with low vitamin B12 status in the presence of elevated folate levels had 
biologically aged 27 years beyond their nutrient-sufficient, age-equivalent counterparts. 
While the mean age of the low B12/elevated folate group is slightly higher than the total 
sample population mean age (54.0 years and 50.1 years, respectively), these middle-aged 
adults are biologically-aged closer to the oldest age category (mean age 72.0 years) with 
respect to telomere length.  
Aging is the most influential, non-modifiable factor for telomere length. Youth is 
strongly associated with longer telomeres, and a linear decline occurs with age, regardless 
of intervening factors (Blackburn et al., 2015; Rode et al., 2015). Our data yielded less 
variation in telomere length among the younger (20–39 years) and older (>60 years) 
groups compared to those of middle age (40–59 years). The difference in mean telomere 
length (longest to shortest) within each of the three age categories (youngest to oldest) 
were 144.5 bp, 420.5 bp, and 143.3 bp, respectively. Thus, difference in mean telomere 
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length from the shortest to the longest, for those 40–59 years old is nearly three-fold that 
of the other two age groups, indicating greater telomeric variability within the middle-
aged.  
In contrast, when vitamin B12 status was sufficient, elevated folate did not have a 
negative effect on telomere length in this same group of middle-aged adults and could be 
viewed as protective. Our findings were in line with those reported by Morris et al. 
(2007) who reported finding a protective effect of higher folate concentrations when 
vitamin B12 levels were sufficient versus low. Morris et al. reported poorer cognitive 
functioning in older adults with low B12 levels in the presence of elevated folate 
compared to normal folate levels. However, when B12 was sufficient, less cognitive 
impairment was observed when folate levels were elevated compared to when they were 
normal (Morris et al., 2007).  
The findings from our study are of public health importance, in that the 
consequences of low vitamin B12 status may be more detrimental than previously 
thought. Historically, vitamin B12 deficiency has often been masked by low folate 
concentrations; whereas, repleting serum folate levels corrects the overt symptomatology. 
However, left untreated, chronic vitamin B12 deficiency will result in permanent 
neurological damage.  
Our study’s importance is two-fold. Foremost, to our knowledge, it is the first 
study to demonstrate that low vitamin B12 status is associated with a significantly shorter 
mean telomere length in adult men and women. Previous studies neglected to use 
additional biomarkers, such as methylmalonic acid (MMA), as indicators of vitamin B12 
status, potentially misclassifying individuals with low B12 as sufficient and biasing the 
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study toward the null (Liu et al., 2013; Paul et al., 2014). Telomeric shortening is a 
known response to oxidative stress, and shorter telomeres are associated with numerous 
chronic health conditions.  If telomere length is used as an indicator of overall health 
status, individuals with low B12 status are at greater risk than those sufficient in the 
nutrient.  
Secondly, had our study solely used the current diagnostic cutoff for vitamin B12 
deficiency of <148 pmol/L to categorize status, we would have failed to identify 13.3% 
of the population who had low vitamin B12 status. This would be equivalent to 43.2 
million people in the United States, for whom low vitamin B12 status could go 
undiagnosed. Low vitamin B12 status could pose a significant medical and financial 
burden on our already strained healthcare system.  
Our finding of a nearly significant interaction between B12 and folate status, age 
and telomere length is of public health importance. We did find a significant association 
between low B12 and elevated folate status and telomere length among middle-aged 
adults. The molecular mechanism behind the negative effects of elevated folate on 
telomere attrition in middle-aged adults with low B12 status remains elusive. While our 
data indicate a possible protective effect provided by elevated folate when B12 status is 
sufficient, elevated folate levels should be considered potentially harmful when vitamin 
B12 status is low. Folic acid fortification programs may need to consider the possible 
population benefits of concomitant fortification with vitamin B12. The potential negative 
impact of elevated folate status in the presence of low vitamin B12 warrants further 
investigation.  
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E. Strengths and Limitations 
This study provides a novel finding concerning vitamin B12 status and telomere 
length. We utilized an additional measure of vitamin B12 (MMA) to more accurately 
capture the B12 status of our population. To our knowledge, this has not previously been 
done with the aim of investigating vitamin B12 status and telomere length.  
In addition, we investigated the joint classification of vitamin B12 and folate status 
on telomere length, which we believe to be an innovative concept. Additionally, our data 
were taken from the NHANES (1999-2002), a nationally representative database, which 
provided a large and diverse sample population.  
Limitations of this study include the cross-sectional study design structure, which 
does not allow for determinations of causality. Telomere length was measured using real-
time PCR, which may not be as accurate at measuring absolute telomere length as the 
Southern Blot method. We also did not use weighted data; thus, we are unable to 
extrapolate percentage findings to the general U.S. population.  
F. Areas of Further Study 
While we did not investigate dietary or supplemental vitamin B12 or folate/folic 
acid data in this study, we believe it is an area with future research potential for those 
studying food patterns, given the metabolic complexity and dichotomy of dietary sources 
for nutrients involved in one-carbon metabolism. Nonetheless, serum and plasma 
biomarkers are viewed as superior indicators of overall nutrient status to dietary intake 
data. In addition, we feel it would be of great interest to examine the association of 
vitamin B6 (pyridoxal 5’ phosphate, PLP) and telomere length given its role in one-
carbon metabolism, as well as its role in neurotransmitter synthesis. To date, only one 
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study examined PLP in relation to telomere length and no association was found. 
However, the authors found a significant relationship between high plasma cysteine 
levels and shorter telomere length (Liu et al., 2013). Cysteine is produced from 
homocysteine in a double vitamin B6-dependent enzymatic process with serine. The 
authors encourage caution in interpreting the results due to the lack of a significant linear 
trend.  
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CHAPTER 3 
 
IRON STATUS AND TELOMERE LENGTH IN ADULT MEN AND WOMEN 
 
A. Introduction 
 
Telomeres are repetitive, non-coding nucleotide sequences at the end of 
chromosomes (5’- TTAGGG – 3’) which protect them against damage during replication. 
Telomeric shortening occurs during cellular division, and cells undergo apoptosis when 
telomeres reach critical length, as part of the normal aging process. However, shorter 
telomeres have been associated with several chronic conditions such as cardiovascular 
disease, hypertension, type 2 diabetes, Alzheimer’s disease, and certain cancers, 
independent of chronological age. Thus, suggesting its role as biomarker for aging in 
eukaryotic cells.  
Oxidative stress has also been linked to several of the aforementioned chronic 
conditions, as well as the process of aging including shortened telomere length 
(Tomiyama et al., 2012; Von Zglinicki & Martin-Ruiz, 2005). Iron, an essential 
micronutrient, has been investigated for its role in oxidative damage. Nearly 65% of iron 
in the body is associated with hemoglobin; however, the importance of iron extends well 
beyond its oxygen carrying ability. The remaining iron is stored in hepatocytes as ferritin 
and hemosiderin (as Fe+3), or in the spleen, bone marrow, and/or muscle tissue. Iron is 
involved in numerous metabolic processes as a part of heme in a cluster with sulfur, or by 
itself.  It functions as a component of proteins involved in DNA synthesis, such as 
ribonucleotide reductase, and part of the catalytic site of cytochromes and peroxidases. 
Iron also acts as a cofactor for dozens of enzymes, including the reactive oxygen species 
(ROS) quenching enzymes catalase and myeloperoxidase (Gropper et al., 2009a).  
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Reactive oxygen species such as the superoxide radical (O2
●), hydroxyl radical 
(●OH), and hydrogen peroxide (H2O2) are generated in the body and are typically 
quenched by antioxidants and/or enzymes. However, a disruption in the equilibrium and 
subsequent ROS overload, can result in oxidative damage. Ferric iron (Fe+2) is released in 
high concentrations from lysosomal apoptosis resulting from the cell damage. This 
excessive free iron can be a catalyst for further reactions (i.e. Fenton reaction) from 
which ROS are formed; thus perpetuating the cycle and leading to oxidative stress 
(Kepinska et al., 2015).  
Research on elevated iron status and telomere length has demonstrated 
dichotomous results (Mainous III et al., 2014; Mainous III et al., 2013; Shin & Baik, 
2017). Mainous III et al. found that high transferrin saturation percentage (TS%) was 
associated with shorter telomere length in their 2013 study of 1,009 predominantly Non-
Hispanic white participants. However, in a subsequent study by Mainous III et al. (2014), 
the researchers found no significant association between elevated TS% and telomere 
length after adjusting for confounders in a sample of 669 participants of mixed 
race/ethnicity.   
To our knowledge, no study has investigated the association of iron deficiency or 
iron deficiency anemia (IDA) on telomere length. Iron deficiency is a leading risk factor 
for death worldwide, and common among women and children (Zimmermann & Hurrell, 
2007). In the United States, 9–11% of nonpregnant women between the ages of 16 and 49 
years are iron deficient, with 2–5% having IDA (World Health Organization, 2017). 
Among older adults, IDA is associated with a higher risk of falls, increased 
hospitalization, impaired mental function, and an increased risk of death (World Health 
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Organization, 2017). Oxidative stress and lower antioxidant levels have been reported in 
iron deficient subjects (Pra et al., 2012). Iron restriction has been shown to decrease DNA 
synthesis and cell proliferation, and reduce ribonucleotide reductase activity, all leading 
to genomic instability (Pra et al., 2012). Thus, providing more reason to explore the 
association of ID/IDA on telomere length.   
 Our aim was to investigate the association of iron status on telomere length in 
adult men and women from a nationally representative sample. We hypothesized that 
men and women with either suboptimal or elevated iron status would have a shorter mean 
telomere length compared to those with normal iron status.  
B. Material and Methods 
1. Study Population 
Data from NHANES (National Health and Nutrition Examination Survey) cycles 
1999-2000 and 2001-2002 were used in the analyses. The NHANES is conducted by the 
National Center for Health Statistics (NCHS), which is part of the Centers for Disease 
Control and Prevention (CDC) and is responsible for publishing health statistics on a 
nationally representative sample of the US population. The NHANES survey data include 
information on demographic, socioeconomic, dietary, and health-related questions, as 
well as a laboratory and physical examination component. Participants are selected using 
a multistage cluster sampling design with oversampling of persons aged 60 and older, 
African Americans, and Hispanics.  
Eligible participants included men and women aged 20 years and older who had 
blood stored for DNA analysis and subsequent mean T/S ratio data available (n = 7827). 
All eligible participants had complete data on sex, C-reactive protein (CRP) levels, and at 
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least two of the following variables used to categorize iron status: serum iron, serum 
ferritin, erythrocyte protoporphyrin concentration, transferrin saturation percentage, 
and/or hemoglobin levels.  
Exclusion criteria included men and women with an elevated serum creatinine 
(1.7 mg/dL (n = 85) or 1.5 mg/dl (n = 45), respectively), and those with liver and kidney 
disease. The kidneys are responsible for producing erythropoietin, a hormone that 
prompts bone marrow to synthesize red blood cells (RBC). Thus, kidney disease often 
results in fewer RBCs and anemia; while chronic liver disease is frequently associated 
with hematological abnormalities including iron deficiency anemia and iron overload.  
 Liver disease was defined as those who answered yes MCQ170L (do you still 
have a liver condition) (n = 155), as well as those with elevated liver enzymes (ALT 
≥125 U/L, AST ≥80 U/L, and Alkaline Phosphatase ≥169 U/L; three standard deviations 
above the mean) (n = 2). Kidney disease was defined as those who answered yes to 
questions KIQ020 (ever told you had weak/failing kidneys) (n = 211). Women with a 
positive pregnancy test (code URXPREG) were also excluded (n = 445), bringing the 
loss of participants to 943. After reviewing for outliers and/or possible erroneous values 
via scatterplot data, participants with serum ferritin levels >500 ng/mL (n=172), mean 
telomere length greater than 10,000 bp (n=3), and those with a serum iron level greater 
than three standard deviations above the mean were excluded from the study (n=10). The 
inclusion of covariates (described below) brought the total number of participants with 
complete data available for the multiple linear regression analyses to 5,908.   
2. Variables 
a. Telomere Length 
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Telomere length was our primary outcome. With each NHANES data collection 
cycle, blood samples are obtained and analyzed immediately. A small portion of the 
blood was reserved for future analysis of DNA, including telomere length. The telomere 
length assay was performed by Dr. Elizabeth Blackburn at the University of California, 
San Francisco (Cawthon, 2002). Polymerase chain reaction (PCR) methodology was used 
to measure the telomere length (T) relative to a standard reference DNA (S) producing a 
T/S ratio. Samples had been assayed in duplicate, three times on three different days, 
resulting in 6 data points that were then averaged. The final interassay coefficient of 
variation was 6.5%. The formula reported in the NHANES database for converting T/S 
ratio to a more intuitive base pair variable is (3,274 + 2,413 * (T/S)). This formula is 
calculated based on the comparison of telomeric restriction fragment (TRF) length from 
Southern Blot analysis and T/S ratios using DNA samples from the human diploid 
fibroblast cell line IMR90 (Cawthon, 2002; Needham et al., 2013).  
b. Iron Status  
The main exposure was iron status, which was determined using an algorithm of 
serum iron (Fe), serum ferritin, erythrocyte protoporphyrin level (EPP), transferrin 
saturation percentage (TS%), C-reactive protein level (CRP), hemoglobin level (hb) and 
sex. Cutoff levels for determining iron status were taken from the World Health 
Organization (WHO) (World Health Organization, 2001) and Iron Status Indicators 
(Cusick, Looker, Cogswell, Pfeiffer, & Grummer-Strawn, 2008).  
Serum iron measures the amount of ferric (Fe3+) iron in the body mainly bound to 
transferrin (a primary iron transport protein). This measurement does not capture the 
divalent iron bound to hemoglobin. Serum iron level alone is not a good indicator of 
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overall iron stores, nor is it a sensitive measure for iron deficiency (Cusick et al., 2008). 
Therefore, it was used in conjunction with other measures of iron in defining iron status.  
Ferritin, the primary storage protein for iron, is widely used to indicate available 
iron in the body. Low ferritin levels (<15 ug/L) are highly associated with iron deficiency 
(ID) and iron deficiency anemia (IDA) (Cusick et al., 2008; World Health Organization, 
2001). However, ferritin is an acute phase respondent and levels will rise in response to 
inflammation. In participants with elevated ferritin levels (>200 ng/mL and >300 ng/mL 
for women and men, respectively), we used a CRP cutoff value of >10 mg/L to indicate a 
possible acute-phase response of ferritin to inflammation. These participants were 
classified with sufficient iron status if they did not have at least one additional biomarker 
of abnormal iron status.   
Hemoglobin (Hb) is also widely used in diagnosing anemia, specifically IDA, 
since it binds approximately 70% of the body’s total iron. We used the WHO cutoff for 
IDA of <12 g/dL Hb for women, and <13 g/dL Hb for men as an acceptable co-
biomarker for suboptimal iron status (World Health Organization, 2001).    
Erythrocyte protoporphyrin (EPP) is a precursor of heme and levels rise when 
iron stores are inadequate for hemoglobin production. In addition to ID, infection, 
inflammation, and lead-poisoning will also result in an elevated EPP level. In the absence 
of infection, measurement of EPP is the preferred method for detecting ID once ferritin 
levels drop below normal (World Health Organization, 2001).  
Transferrin saturation percentage (TS%) is the measure of total iron bound to 
transferrin, an iron transport protein, and is the ratio of serum iron to the total iron 
binding capacity of transferrin (TIBC). A TS% <16 is indicative of IDA (Zimmermann & 
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Hurrell, 2007), while excess of ≥55% indicates iron overload, or hemochromatosis 
(Mainous III, Gill, & Carek, 2004). A TS% of <20 is considered indicative of suboptimal 
iron status.  
3. Iron Status Categorization 
We used the above-mentioned biomarkers of iron status to categorize participants 
as having suboptimal, sufficient, or elevated iron status. Participants were considered to 
have suboptimal iron status if they had two or more of the following criteria: a serum 
ferritin level ≤15 µg/L, EPP level >80 µg/dL, TS% <20, or Hb <12 for women and <13 
for men.  
To define elevated iron status, we used one or more of the following criteria: TS% 
≥50, serum iron level of ≥155 µg/dL for women or ≥160 µg/dL for men, serum ferritin 
level of ≥150 µg/L for women or ≥200 µg/L for men along with a CRP <10 mg/L. 
Participants with elevated ferritin and elevated CRP levels, but no other abnormal 
markers for iron status were classified as sufficient. Participants were classified with 
sufficient iron status if they did not meet the set criteria for suboptimal or elevated iron 
status. Thus, participants sufficient in iron had serum ferritin levels ≥15 µg/L and <150 
µg/L for women and <200 µg/L for men, EPP levels <80 µg/dL, Hb ≥12 g/dL for women 
and ≥13 g/dL for men, TS% ≥20 and <50, and serum iron levels <155 µg/dL for women 
and < 160 µg/dL for men.      
 
4. Demographic Data 
The demographic covariates for this study included age, sex and race/ethnicity. 
Age was a continuous variable in years, sex was coded “male” or “female,” and 
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race/ethnicity was coded “White/non-Hispanic,” “Mexican/Hispanic,” “Black/non-
Hispanic,” and “Other/Multi-Racial.”  
Markers of socioeconomic status included educational status and annual 
household income. Educational status consisted of “≤11th grade,” “high school graduate 
or GED equivalent,” and “some college or beyond.” Annual household income was 
determined to be non-significant in the model and was later dropped from further 
analyses.   
Smoking status was categorized as “never,” “former,” and “current” smokers. 
Current smokers were further categorized by average number of cigarettes smoked per 
day.  The “never” group consisted of those participants who answered no to question 
SMQ020 (smoked at least 100 cigarettes in life?). Former smokers were those who 
answered yes to SMQ020, but no to SMQ040 (do you now smoke cigarettes?). Current 
smokers were those who answered 1 or 2 (every day or some days, respectively) to 
question SMQ040 (do you now smoke cigarettes?). This group was further categorized 
using the answer to question SMD070 (# cigarettes smoked/day now?), into <10 
cigarettes/day, 10 to 19 cigarettes/day, and ≥20 cigarettes/day. The smoking variable was 
based on cigarette smoking only. Other methods of smoking or use of chewing tobacco 
were not assessed.  
Alcohol intake was categorized as “never,” “former moderate,” “former heavy,” 
“current moderate,” and “current heavy.” Never drinkers were those answering no to 
having had at least 12 alcoholic drinks over the past 12 months and no to having had at 
least 12 alcoholic drinks in a lifetime. Former drinkers were those who answered yes to at 
least 12 drinks in a lifetime, but no to having consumed alcohol over the past 12 months. 
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Former drinkers were divided into moderate and heavy intakes. Heavy drinkers answered 
yes to ever having ≥ five drinks every day. Current drinkers were also divided into 
moderate and heavy alcohol intake. Current moderate drinkers consumed an average of ≤ 
two drinks/day, while current heavy drinkers consumed ≥ three drinks/day. Blood 
glucose status was defined as normal, borderline, and diabetes using an algorithm of 
biochemical markers including percent hemoglobin A1c (%A1c), fasting and non-fasting 
plasma glucose levels, as well as medical history questionnaire data. Participants were 
categorized as having diabetes if they answered yes to taking insulin, to having been told 
they have diabetes by a doctor, and/or to taking oral glucose agents. Biochemical data for 
diabetes included a %A1c of ≥6.5, a fasting plasma glucose of ≥126 mg/dL, a plasma 
glucose of ≥ 200 mg/dL, and/or a fasting glucose of ≥126 mg/dL with an %A1c ≥5.7, but 
<6.5. Participants were categorized as borderline blood glucose status if they answered 
yes to having been told they have pre-diabetes. Biochemical data for borderline diabetes 
included a %A1c ≥5.7 but <6.5% with a fasting plasma glucose ≥100 mg/dL, but <126 
mg/dL. The remaining participants were categorized as having normal blood glucose 
status if they did not meet the above criteria for impaired glucose. Those lacking data on 
two or more of these markers were categorized as missing.  
 
C. Statistical Analysis 
 Data analyses were performed using STATA/IC version 13.1 to test our 
hypothesis that low, as well as elevated iron status is associated with shorter telomere 
length in adult men and women. The continuous variables included age, body mass index 
(BMI), serum iron concentration, serum ferritin level, transferrin saturation percentage 
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(TS%), erythrocyte protoporphyrin (EPP) concentration, and hemoglobin (Hb) level were 
reported as the adjusted mean (SE) by sex and iron status (suboptimal, sufficient, 
elevated). Categorical variables included race, educational status, annual household 
income, smoking status, alcohol intake status, and blood glucose status, and were 
reported as counts (%) by sex and iron status. The age-adjusted mean telomere length 
was calculated for the categorical variables by sex and exposure status. Two-sample T-
test, Analysis of variance (ANOVA) and Chi-Squared test were used to examine whether 
covariate distributions differed across sex and iron status subgroups (suboptimal, 
sufficient, elevated). A p-value of < 0.05 was considered statistically significant for all 
tests. The main outcome and exposures had equal variances based on results of Levenes’s 
test for homoscedasticity. 
We tested our main hypotheses by iron status and telomere length in a multiple 
linear regression model adjusting for potential cofounding variables. The above-
mentioned covariates were assessed for their effect on telomere length or confounding 
with iron status. A multiple F-test was used to test the significance of the parameters in 
the model. If a variable demonstrated no effect on the relationship between telomere 
length and our exposure variables (p>0.05) the parameter was eliminated from the model. 
The normality of the continuous variables was assessed via graphical methodology, T/S 
ratio and BMI were subsequently log-transformed to achieve greater homoscedasticity.  
We presented the telomere data as base pair units.  
We conducted a linear regression model of iron status and telomere length 
adjusting for age alone, reported in model 1. Data are presented as the change in mean 
telomere length base pair (bp). We used the log-transformed mean telomere (T/S) ratio in 
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the linear regression analysis, prior to the calculation of bp, to determine the β coefficient 
for age. We later used this value in determining an estimate of telomeric shortening 
associated with biological aging. The regression coefficient for age was -0.0059 (0.6%), 
which corresponded to telomere length reduction of 14.3 bp per each one-year increase in 
participant age. Model 2 represents the multiple linear regression that included race and 
sex, in addition to age. We chose to conduct the analyses in stages due to the particularly 
strong correlation of these three variables with telomere length. Model 3 is the fully-
adjusted model that builds on model 2 by including BMI, educational status, smoking 
status, and alcohol intake status.   
To investigate effect modification, we created interaction terms for iron status and 
sex, race, and age. We tested the interaction terms for significance in the various models. 
If significant, we stratified the linear regression models by the variable and utilized 
multiple F-test analysis for significance.   
 
D. Results 
1. Descriptive Statistics 
 Table 3.1 presents descriptive data for the 5,908 participants by sex in our study 
population (50.4% female). The mean ages for men and women were 50.0 and 50.4 
years, respectively. Non-Hispanic (NH) white participants made up 52.4% of the 
population, 16.9% were NH-black, 28.1% were Mexican/Hispanic, and 2.6% were multi-
racial. Given the small sample size of the multi-racial group, we consider any significant 
findings to be only suggestive.  
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The mean age of men with suboptimal iron status was significantly older than the 
mean age of women with suboptimal iron status. Whereas the mean age for women with 
elevated iron status was significantly higher compared to men (p <0.001). Furthermore, 
men and women with suboptimal and elevated iron status, separately, differed 
significantly in all iron status parameters except for erythrocyte protoporphyrin levels 
among those with suboptimal iron status and serum iron among those with elevated iron 
status. C-reactive protein (CRP) was significantly higher among those with suboptimal 
iron status compared to those with sufficient iron status, and tended to be higher overall, 
in women compared to men. Body mass index (BMI) also tended to be higher in women 
compared to men (Table 3.1).   
A greater percentage of women (17.3%) had suboptimal iron status compared to 
men (4.0%). Whereas men had a higher prevalence of elevated iron status compared to 
women (30.5% and 13.3%, respectively). Elevated iron status was similar among all 
racial/ethnic groups (Table 3.1). NH-black participants were more likely to have 
suboptimal iron status (14.6%) compared to NH-white (8.8%), Mexican/Hispanic 
(12.2%), or multi-racial (7.7%) participants. When stratified by sex, a significantly higher 
percentage of NH-black and Mexican/Hispanic women had suboptimal iron status 
compared to NH-white women.  
The distribution of blood glucose status was similar between men and women, 
with 11.4% of men and 10.5% of women having diabetes. Among male participants with 
diabetes, 39.3% had elevated iron status, while only 29.4% and 28.9% of men with 
normal and borderline blood glucose, respectively, had elevated iron status. A similar 
pattern was found in women; 18.5% of women with diabetes had elevated iron status, 
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whereas 12.2% and 15.7% of those with normal and borderline blood glucose, 
respectively, had elevated iron status (Table 3.1).   
Women of all ethnic/racial groups had longer mean telomere lengths than men; 
furthermore, NH-black women had the longest age-adjusted mean telomere length 
(5943.5 bp) of all ethnic/racial groups, followed by NH-black men (5855.5 bp) (Table 
3.2).  
 
2. Inferential Statistics 
a. Iron Status and Telomere Length  
 Table 3.3 represents data from multiple linear regression models of iron status 
and telomere length. In the age-adjusted model (Model 1), elevated iron status was 
significantly associated with shorter telomere length (β = -48.8 bp, p=0.007). After 
adjusting for race and sex in addition to age (Model 2), the effect was reduced slightly 
while remaining significant (β = -41.1 bp, p=0.025). The fully-adjusted model included 
the addition of body mass index (BMI), educational status, smoking status, and alcohol 
intake status (Model 3). Annual household income and blood glucose levels were not 
significant in the model and were therefore omitted from further investigation. In the 
fully adjusted model (Model 3), elevated iron status remained significantly associated 
with shorter telomere length (β = -36.7 bp, p=0.045). Suboptimal iron status was not 
associated with telomere length in any models analyzed.  
 The model-based estimate of age-related telomeric attrition in this study was -
0.0059 (0.6%), which corresponded to 14.3 bp. Thus, each year of chronological 
“normal” aging was associated with a telomeric loss of 14.3 bp. The difference in 
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telomere length in participants with elevated iron status (-36.7 bp) would be equivalent to 
2.6 years of additional “biological” aging in this group.  
 
b. Interaction of Iron Status and Sex, Race, or Age 
 The interaction term of iron status and sex was not significant (p = 0.67), nor were 
the interaction terms of iron status and race (p = 0.61) or iron status and age (p = 0.63). 
Thus, no further analyses were performed on the interaction terms.  
 
E. Discussion 
 There is evidence that elevated iron status is associated with shorter telomere 
length (Mainous III et al., 2013), but the results have been inconsistent (Mainous III et 
al., 2014). We expanded our investigation to include suboptimal iron status, in addition to 
elevated iron status, given the high prevalence of iron deficiency (ID) in the United 
States, where 10% of Non-Hispanic (NH)-whites, 19% of NH-blacks and 22% of 
Mexican/Hispanics aged 20 – 49 years are iron deficient. (US Department of Health and 
Human Services. Centers for Disease Control and Prevention., 2002).  
 We found a small, but statistically significant association between elevated iron 
status and shorter mean telomere length among adult men and women from this 
nationally representative sample. The model-based estimate for biological aging using the 
T/S ratio β-coefficient for age of -0.006% (equivalent to -14.3 base pairs) suggested that 
those with elevated iron status are biologically two and one-half years older than their 
iron-sufficient counterparts. Although the distribution of iron data was different between 
men and women, as well as between the ethnic/racial groups and age, we did not find a 
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significant interaction between the tested variables, indicating no effect modification by 
sex, race, or age on iron status.  
 Elevated iron status, primarily as hemochromatosis, has been associated with 
detrimental health outcomes including cirrhosis of the liver, pancreatic dysfunction 
leading to diabetes, and cardiovascular disease (Richardson, Mcnamee, & Simmonds, 
2018). We were not able to assess occurrence of the HFE mutation which leads to 
hereditary hemochromatosis in our study population. However, Mainous III and 
colleagues (2013) found that elevated iron phenotype, but not hemochromatosis (HFE 
genotype) was associated with shorter telomere length, indicating that it may be the 
elevated iron status rather than the specific genetic makeup that is associated with 
telomeric attrition. 
 Although we did not find a significant association with impaired blood glucose 
levels and telomere length, we did note that a significantly greater percentage of 
participants with diabetes had an elevated iron status (39.3%) compared to those with 
normal blood glucose levels (29.4%). This finding is in concordance with previous data 
supporting an increased risk of diabetes associated with elevated iron status (Montonen et 
al., 2012).  
Non-Hispanic (NH) black participants were more likely to have suboptimal iron 
status, as were women; however, this did not reflect in a shorter mean telomere length for 
either group. Overall, we did not find a significant association between suboptimal iron 
status and shorter telomere length, although our study had sufficient power to observe a 
relationship if one indeed existed. While all participants were categorized with at least 
two biomarkers of iron deficiency, we used a transferrin saturation percentage (TS%) 
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cutoff of <20%, rather than the 16% indicated by the World Health Organization (WHO) 
to define iron deficiency (ID). Nonetheless, the cutoff of <20% had also been suggested 
in defining poor iron status (Daniels, 2010). In our study, 195 of the 750 participants with 
suboptimal iron status had a TS% ≥16 but <20%. Of these participants, 112 had serum 
ferritin levels >15 µg/L but met at least one of the remaining criteria for suboptimal iron 
status. No difference was found when suboptimal iron status was classified using TS% of 
≤16 compared to <20% in our analyses. 
Iron deficiency is the most common nutritional disorder in the world, and is 
associated with increased levels of oxidative stress and decreased antioxidant defenses 
(Pra et al., 2012). While iron is essential for DNA synthesis via ribonucleotide reductase, 
suboptimal iron status does not appear to be associated with telomeric attrition as we 
initially hypothesized. To our knowledge, there are no published studies on iron 
deficiency and telomere length.  
 
F. Strengths and Limitations 
  This study filled a knowledge gap on suboptimal iron status and telomere length 
in adult men and women. We utilized multiple biomarkers of iron in determining 
suboptimal and elevated iron status. By doing so, we strengthened our ability to correctly 
identify participants who were truly suboptimal or who had elevated iron status. 
Furthermore, our data was taken from the National Health and Nutrition Examination 
Survey (NHANES 1999 – 2002) which provided a large, diverse sample population.  
 
1. Limitations 
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Micronutrient status can be difficult to study in vivo due to the challenges in 
obtaining valid biomarker data. Determinants of iron status are known to fluctuate 
depending on certain health parameters. For example, chronic disease and acute 
infections may result in abnormal hematology; thus, making an accurate assessment 
based on one timepoint come into question. It is possible, despite our best efforts, that we 
misclassified participants within the suboptimal and sufficient groups, thus nullifying the 
results. Further limitations include the cross-sectional study design structure, which does 
not allow for determinations of causality. We also did not use weighted data; thus, we are 
unable to extrapolate percentage findings to the general U.S. population.  
 
G. Area of Future Research 
Further research on the potential association between suboptimal iron status and 
telomere length is warranted. Well-designed prospective studies that include dietary and 
biomarker data on micronutrient intake and status would contribute to answering 
questions on causality.  
 
 
H. Summary 
 A common thread in the progression of aging is the accrual of genetic/DNA 
damage. Premature aging diseases, such as Werner and Bloom syndromes, have provided 
insight into how DNA instability accelerates the aging process, but do not completely 
elucidate the matter. Telomeric attrition is considered to be a primary hallmark of aging 
and thus, measurement of telomere length has been proposed to be an indicator of 
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biological aging (Aviv, 2002; López-Otín et al., 2013). Nutrient status is a modifiable 
factor that has been associated with telomere length.  
 In our study, less than optimal micronutrient status was significantly associated 
with a shorter mean telomere length. Specifically, after stratifying by age, we found a 
significant interaction between low vitamin B12 and elevated folate status in middle-aged 
adults. The telomeric attrition of 382 base pairs in this group was equivalent to nearly 27 
years of additional biological aging using the model-based estimate for aging. This 
interaction was not observed in the younger or older age groups; however, middle-age 
could be considered the most vulnerable time for telomeres. Telomere length in this age 
group was also the most variable in our study, suggesting that telomeres during middle-
age may be more susceptible to factors influencing attrition, such as poor nutrient status.  
 Similarly, we found a negative association between elevated iron status and 
telomere length. Although we hypothesized a relationship, we did not find an association 
between suboptimal iron status and telomere length. Furthermore, we did not find an 
interaction between iron and age, and therefore could not support our previous findings in 
middle-aged adults. Overall, our study was novel in approach, and successfully 
contributed to the current literature on micronutrient status and telomere length.    
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             Table 1.1: 
Age-adjusted characteristics of eligible participants from the National Health and Nutrition Examination Survey (1999-2002) 
by vitamin B12 and folate status (N=5,941). 
 
 
Total 
Mean (SE) 
Low  
B12 status
2 
Sufficient  
B12 Status 
 
p-values 5 
Suboptimal 
Folate Status3 
Sufficient 
Folate Status 
Elevated  
Folate Status4 
 
p-values5 
Age (yrs) 50.1 (0.2) 58.0 (0.6) 48.7 (0.3) < 0.001 43.7 (0.9) 48.5 (0.3) 60.5 (0.6) < 0.001 
Body Mass Index (kg/m2) 28.3 (0.1) 27.9 (0.2) 28.4 (0.1) <0.001 29.0 (0.3) 28.4 (0.1) 27.3 (0.2) < 0.001 
Serum B12 (pmol/L) 387.3 (3.8) 291.0 (9.7) 405.0 (4.0) < 0.001 325.8 (14.6) 374.3 (4.2) 473.3 (9.5) < 0.001 
MMA (nmol/L) 151.6 (1.3) 305.2 (2.9) 123.3 (1.2) < 0.001 167.3 (5.4) 151.6 (1.5) 131.0 (3.5) NS 
Serum Folate (nmol/L) 32.0 (0.2) 28.3 (0.5) 32.7 (0.2) 0.02 11.3 (0.4) 27.9 (0.1) 59.5 (0.3) < 0.001 
CRP (mg/L) 4.5 (0.1) 4.4 (0.3) 4.5 (0.1) NS 6.2 (0.4) 4.4 (0.1) 4.0 (0.3) 0.005 
Homocysteine (umol/L) 8.7 (0.0) 10.5 (0.1) 8.4 (0.0) < 0.001 12.3 (0.2) 8.7 (0.0) 7.4 (0.1) < 0.001 
 
Total 
N (%) 
Low B12  
Status2 
Sufficient B12 
Status 
p-values5 
Suboptimal 
Folate Status3 
Sufficient 
Folate Status 
Elevated  
Folate Status4 
p-values5 
Gender 
    Males 
    Female 
 
3016 (50.8) 
2925 (49.2) 
 
488 (53.0) 
433 (47.0) 
 
2528 (50.4) 
2492 (49.6) 
 
NS 
 
215 (54.7) 
178 (45.3) 
 
2408 (52.7) 
2165 (47.3) 
 
393 (40.3) 
582 (59.7) 
< 0.001 
Race 
     Non-Hispanic White  
     Mexican/Hispanic  
     Non-Hispanic Black  
     Multi-Racial    
 
3085 (51.9) 
1676 (28.2) 
1021 (17.4) 
159 (2.7) 
 
589 (64.0) 
210 (22.8) 
88 (9.6) 
34 (3.7) 
 
2496 (49.7) 
1466 (29.2) 
933 (18.6) 
125 (2.5) 
 
< 0.001 
 
164 (41.7) 
109 (27.7) 
109 (27.7) 
11 (2.8) 
 
2212 (48.4) 
1396 (30.5) 
843 (18.4) 
122 (2.7) 
 
709 (72.7) 
171 (17.5) 
69 (7.1) 
26 (2.7) 
< 0.001 
Education  
    Less than 11th Grade  
    High School Graduate  
    Some College/Beyond 
 
1931 (32.5) 
1410 (23.7) 
2600 (43.8) 
 
354 (38.4) 
243 (26.4) 
324 (35.2) 
 
1577 (31.4) 
1167 (23.3) 
2276 (45.3) 
 
< 0.001 
 
93 (23.7) 
157 (40.0) 
143 (36.4) 
 
1519 (33.2) 
1106 (24.2) 
1948 (42.6) 
 
255 (26.2) 
211 (21.6) 
509 (52.2) 
< 0.001 
Income  
    Less than $19K/yr  
   $20K - $54K/yr  
   Greater than $55K/yr  
 
1222 (23.0) 
2298 (43.3) 
1789 (33.7) 
 
250 (30.0) 
351 (42.1) 
233 (27.9) 
 
972 (21.7) 
1947 (43.5) 
1556 (34.8) 
 
< 0.001 
 
101 (29.3) 
152 (44.1) 
92 (26.7) 
 
925 (22.6) 
1775 (43.4) 
1388 (34.0) 
 
196 (22.4) 
371 (42.3) 
309 (35.3) 
0.01 
Smoking Status 
    Never Smoker  
    Former Smoker  
    <10 cigs/d 
    10 – 19 cigs/d 
    >=20 cigs/d 
 
3139 (52.8) 
1650 (27.8) 
274 (4.6) 
338 (5.7) 
540 (9.0) 
 
461 (50.1) 
286 (31.1) 
33 (3.6) 
46 (5.0) 
95 (10.3) 
 
2678 (53.4) 
1364 (27.2)  
241 (4.8) 
292 (5.8)  
445 (8.9) 
0.026 
 
 
176 (44.8) 
63 (16.0) 
34 (8.7) 
42 (10.7) 
78 (19.9) 
 
2403 (52.6) 
1269 (27.8) 
220 (4.8) 
276 (6.0) 
405 (8.9) 
 
560 (57.4) 
318 (32.6) 
20 (2.1) 
20 (2.1) 
57 (5.9) 
< 0.001 
Alcohol Intake  
   Never  
   Former Moderate 
   Former Heavy 
   Current Moderate 
 
888 (15.0) 
866 (14.6) 
266 (4.5) 
2516 (42.4) 
 
181 (19.7) 
155 (16.8) 
44 (4.8) 
359 (39.0) 
 
707 (14.1) 
711 (14.2) 
222 (4.4) 
2157 (43.0) 
 
 
< 0.001 
 
47 (12.0) 
46 (11.7) 
20 (5.1) 
139 (35.4) 
 
672 (14.7) 
644 (14.1) 
211 (4.6) 
1903 (41.6) 
 
169 (17.3) 
176 (18.1) 
35 (3.6) 
474 (48.6) 
 
 
 
 
< 0.001 
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   Current Heavy  1405 (23.7) 182 (19.8) 1223 (24.4) 141 (35.9) 1143 (25.0) 121 (12.4) 
Blood Glucose Status 
   Normal 
   Borderline 
   Diabetes 
4452 (75.0) 
816 (13.7) 
673 (11.3) 
634 (68.8) 
147 (16.0) 
140 (15.2) 
3818 (76.1) 
669 (13.3) 
533 (10.6) 
<0.001 
309 (78.6) 
54 (13.8) 
30 (7.6) 
3439 (75.2) 
612 (13.4) 
522 (11.4) 
704 (72.2) 
150 (15.4) 
121 (12.4) 
0.043 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Continuous data presented as age-adjusted mean (SE) 
Categorical data presented as N (%) by B12 status and folate status 
1 Low vitamin B12 status defined as serum B12 <148 pmol/L and/or MMA ≥210 nmol/L 
2 Two-sample t-test, significance set at <0.05  
3 Suboptimal folate defined as serum folate ≤13.4 nmol/L 
4 Elevated folate status defined as serum folate ≥45.3 nmol/L 
5 Chi-Squared test, significance set at <0.05  
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Total  
 
Sufficient B12 
Sufficient Folate 
(N = 4,366) 
 
Sufficient B12 
Suboptimal Folate3 
(N = 366) 
 
Sufficient B12 
Elevated Folate4 
(N = 922) 
 
Low B12
2 
Sufficient Folate 
(N = 838) 
 
Low B12
2 
Suboptimal Folate3 
(N = 96) 
 
Low B12
2 
Elevated Folate4 
(N = 151) 
p-values 
RTL (base pairs) 5749.2 (7.0) 5748.4 (9.3) 5661.5 (32.4) 5773.8 (20.0) 5681.5 (21.8) 5703.0 (64.6) 5674.9 (50.9) < 0.001 
Table 1.2: 
Mean telomere length of eligible participants from the National Health and Nutrition Examination Survey (1999-2002) by joint 
classification of vitamin B12 and folate status adjusted for age (N=5,941).
1 
1 Adjusted for age, presented as mean (SE) 
2 Low vitamin B12 status defined as serum B12 <148 pmol/L and/or MMA ≥210 nmol/L 
3 Suboptimal folate defined as serum folate ≤13.4 nmol/L 
4 Elevated folate status defined as serum folate ≥45.3 nmol/L 
5 ANOVA, Significance set at <0.05  
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 Model 11 Model 22 Model 33 
 β, (95%CI) p-value R2 β, (95%CI) p-value R2 β, (95%CI) p-value R2 
B12 Status4 
    Low 
    Sufficient 
 
-56.6 (-97.2, -15.9) 
Ref 
 
0.006 
--- 
0.169 
 
-46.7 (-87.4, -6.0) 
Ref 
 
0.025 
--- 
0.184 
 
-55.1 (-97.1, -13.1) 
Ref 
 
0.01 
--- 
0.193 
Folate Status5 
   Suboptimal 
    Sufficient 
    Elevated 
 
-67.9 (-126.6, -9.2) 
Ref 
25.6 (-14.9, 66.1) 
 
0.023 
--- 
0.216 
0.169 
 
-76.1 (-134.5, -17.8) 
Ref 
14.0 (-27.0, 55.0) 
 
0.011 
--- 
0.504 
0.184 
 
-68.9 (-129.4, -8.4) 
Ref 
7.0 (-34.6, 48.5) 
 
0.026 
--- 
0.742 
0.193 
Table 1.3: 
Multiple linear regression models of vitamin B12 status, folate status, and telomere length in participants from the National Health and 
Nutrition Examination Survey (1999-2002) N=5,941. 
1 Adjusted for age 
2 Adjusted for age, sex, race, B12 or folate status 
3 Adjusted for age, sex, race, B12 or folate status body mass index†, C-reactive protein level†, homocysteine level†, educational status, smoking status, 
alcohol intake status 
4 Low B12 status defined as serum B12 ≤148 pmol/L and/or MMA ≥210 nmol/L 
5 Suboptimal folate status defined as serum folate ≤13.4 nmol/L; elevated folate status defined as serum folate ≥45.3 nmol/L 
† Log-transformed data 
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Mean Telomere Length (bp) 
 
B12/Folate Status 
 
20 – 39 years (n = 2068) p 40 – 59 years (n = 1935) p >60 years (n = 1938) p 
 
Sufficient B12/Sufficient Folate 
 
Sufficient B12/Suboptimal Folate
3 
 
Sufficient B12/Elevated Folate
4 
 
Low B12
2/Sufficient Folate 
 
Low B12
2/Suboptimal Folate3 
 
Low B12
2/Elevated Folate4 
 
Ref 
 
-108.1 (-214.2, -1.9)     
 
-25.6 (-128.8, 77.7)  
 
-131.2 (-230.1, -32.4) 
 
157.9 (-83.8, 399.7) 
 
70.2 (-288.4, 428.8) 
 
-- 
 
0.046 
 
0.627 
 
0.009 
 
0.200 
 
0.701 
 
Ref 
 
-108.3 (-223.6, 7.0) 
 
111.0 (28.2, 193.9) 
 
-1.0 (-91.3, 89.4) 
 
11.9 (-285.7, 309.6) 
 
-382.5 (-658.2, -106.7) 
 
 
-- 
 
0.07 
 
0.009 
 
0.983 
 
0.937 
 
0.007 
 
Ref 
 
-32.0 (-180.9, 116.9) 
 
-33.7 (-92.2, 24.8) 
 
-48.4 (-114.0, 17.1) 
 
203.9 (-48.8, 456.7) 
 
50.9 (-73.7, 175.4) 
 
 
-- 
 
0.673 
 
0.259 
 
0.148 
 
0.114 
 
0.423 
Table 1.4: 
Telomere length by joint classification of vitamin B12 and folate status stratified by age in eligible participants 
from the National Health and Nutrition Examination Survey (1999-2002) (N=5,941).1 
 
 
  Data presented as mean telomere length (95% CI), significance set at 0.05 
1 Adjusted for age, sex, race, BMI†, C-reactive protein level†, homocysteine level†, educational status, smoking status, alcohol intake 
2 Low vitamin B12 status defined as serum B12 <148 pmol/L and/or MMA ≥210 nmol/L 
3 Suboptimal folate defined as serum folate ≤13.4 nmol/L 
4 Elevated folate status defined as serum folate ≥45.3 nmol/L 
† Log-transformed data 
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 Men (N = 2933) Women (N = 2975) 
 
Continuous Data 
Total Men 
Mean (SE) 
Suboptimal 
Iron Status 
Sufficient 
Iron Status 
Elevated  
Iron Status 
Total Women 
Mean (SE) 
Suboptimal 
Iron Status 
Sufficient 
Iron Status 
Elevated  
Iron Status 
Age (years) 50.0 (0.3) 63.3 (1.7)* 49.5 (0.4) 49.3 (0.6)** 50.4 (0.3) 46.3 (0.8)* 50.3 (0.4) 56.2 (0.9)** 
Body Mass Index (BMI) 
(kg/m2) 
27.8 (0.1) 29.2 (0.5) 27.6 (0.1)* 28.1 (0.2) 28.7 (0.1) 30.0 (0.3) 28.4 (0.1)* 28.0 (0.3) 
Serum Iron (µg/dL) 95.3 (0.7) 53.9 (3.2)* 89.9 (0.8)** 112.5 (1.1) 81.3 (0.7) 47.6 (0.4)* 84.4 (0.7)** 108.8 (1.6) 
Serum Ferritin (µg/L) 158.2 (1.7) 81.6 (7.0)* 111.4 (1.7)** 268.2 (2.5)*** 77.0 (1.7) 37.6 (2.6)* 66.0 (1.2)** 187.0 (2.9)*** 
Transferrin Saturation 
Percentage (TS %) 
27.4 (0.2) 13.7 (1.0)* 25.7 (0.2)** 33.0 (0.3)*** 22.3 (0.2) 11.9 (0.4)* 23.2 (0.2)** 31.4 (0.4)*** 
Erythrocyte Protoporphyrin 
(EPP) (ug/dL) 
47.4 (0.7) 87.1 (1.7) 45.9 (0.4)* 45.0 (0.6)** 61.9 (0.7) 106.0 (2.0) 53.1 (1.0)* 50.9 (2.3)** 
Hemoglobin (hb) (g/dL) 15.2 (0.02) 13.6 (0.1)* 15.2 (0.0)** 15.4 (0.0)*** 13.5 (0.02) 12.3 (0.0)* 13.7 (0.0)** 13.8 (0.0)*** 
C-reactive protein (CRP) 
(mg/L) 
3.6 (0.1) 7.7 (0.6)* 3.9 (0.2)** 2.3 (0.2)*** 5.1 (0.1) 6.3 (0.4)* 5.1 (0.2)** 3.4 (0.4)*** 
MCV (fL) 90.5 (0.1) 85.2 (0.4)* 90.5 (0.1) 91.2 (0.2) 89.6 (0.1) 84.7 (0.2)* 90.5 (0.1) 91.3 (0.3) 
Hb A1c % 5.57 (0.0) 5.53 (0.1) 5.54 (0.0) 5.64 (0.0) 5.54 (0.0) 5.62 (0.0) 5.51 (0.0) 5.64 (0.0) 
Categorical Data 
Total Men 
N (%) 
Suboptimal 
Iron Status 
Sufficient 
Iron Status 
Elevated  
Iron Status 
Total Women 
N (%) 
Suboptimal 
Iron Status 
Sufficient 
Iron Status 
Elevated  
Iron Status 
Race 
     Non-Hispanic White  
     Non-Hispanic Black 
     Mexican/Hispanic  
     Multi-Racial    
 
1564 (53.3) 
486 (16.6) 
813 (27.7) 
70 (2.4) 
 
67 (4.3) 
24 (4.9) 
25 (3.1) 
1 (1.4) 
 
1022 (65.4) 
307 (63.2) 
545 (67.0) 
48 (68.6) 
 
475 (30.4) 
155 (31.9) 
243 (29.9) 
21 (30.0) 
 
1530 (51.4) 
511 (17.2) 
848 (28.5) 
86 (2.9) 
 
205 (13.4) 
122 (23.9) 
178 (21.0) 
11 (12.8) 
 
1123 (73.4) 
306 (60.0) 
576 (67.9) 
58 (67.4) 
 
202 (13.2) 
83 (16.2) 
94 (11.1) 
17 (19.8) 
Education  
    Less than 11th Grade  
    High School Graduate  
    Some College 
    Beyond College  
 
974 (33.2) 
670 (22.8) 
666 (22.7) 
623 (21.2) 
 
43 (4.4) 
23 (3.4) 
27 (4.1) 
24 (3.9) 
 
614 (63.0) 
432 (64.5) 
429 (64.4) 
447 (71.8) 
 
317 (32.6) 
215 (32.1) 
210 (31.5) 
152 (24.4) 
 
930 (31.3) 
727 (24.4) 
806 (27.1) 
512 (17.2) 
 
197 (21.2) 
109 (15.0) 
149 (18.5) 
61 (11.9) 
 
599 (64.4) 
507 (69.7) 
566 (70.2) 
391 (76.4) 
 
134 (14.4) 
111 (15.3) 
91 (11.3) 
60 (11.7) 
Income  
    Less than $19K/yr  
   $20K - $54K/yr  
   Greater than $55K/yr  
 
559 (21.2) 
1365 (51.7) 
719 (27.2) 
 
26 (4.7) 
46 (3.4) 
30 (4.2) 
 
373 (66.7) 
874 (64.0) 
486 (67.6) 
 
160 (28.6) 
445 (32.6) 
203 (28.2) 
 
655 (24.9) 
1311 (49.8) 
666 (25.3) 
 
131 (20.0) 
223 (17.0) 
99 (14.9) 
 
445 (67.9) 
905 (69.0) 
483 (72.5) 
 
79 (12.1) 
183 (14.0) 
84 (12.6) 
Smoking Status 
    Never Smoker  
    Former Smoker  
    <10 cigs/d 
    10 – 19 cigs/d 
 
1283 (43.7) 
1018 (34.7) 
145 (4.9) 
175 (6.0) 
 
46 (3.6) 
57 (5.6) 
7 (4.8) 
1 (0.6) 
 
848 (66.1) 
659 (64.7) 
97 (66.9) 
122 (69.7) 
 
389 (30.3) 
302 (29.7) 
41 (28.3) 
52 (29.7) 
 
1862 (62.6) 
617 (20.7) 
123 (4.1) 
159 (5.3) 
 
362 (19.4) 
89 (14.4) 
17 (13.8) 
25 (15.7) 
 
1259 (67.6) 
441 (71.5) 
87 (70.7) 
117 (73.6) 
 
241 (12.9) 
87 (14.1) 
19 (15.5) 
17 (10.7) 
Table 2.1: 
Characteristics of eligible participants from the National Health and Nutrition Examination Survey (1999-2002) by sex and 
iron status (N=5,908). 
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    >=20 cigs/d 312 (10.6) 6 (1.9) 196 (62.8) 110 (35.3) 214 (7.2) 23 (10.8) 159 (74.3) 32 (15.0) 
Alcohol Intake  
   Never  
   Former Moderate 
   Former Heavy 
   Current Moderate 
   Current Heavy  
 
230 (7.8) 
365 (12.4) 
210 (7.2) 
1173 (40.0) 
955 (32.6) 
 
14 (6.1) 
24 (6.6) 
12 (5.7) 
44 (3.8) 
23 (2.4) 
 
157 (68.3) 
241 (66.0) 
141 (67.1) 
780 (66.5) 
603 (63.1) 
 
59 (25.6) 
100 (27.4) 
57 (27.1) 
349 (29.8) 
329 (34.4) 
 
668 (22.5) 
501 (16.8) 
51 (1.7) 
1348 (45.3) 
407 (13.7) 
 
132 (19.8) 
98 (19.6) 
12 (23.5) 
212 (15.7) 
62 (15.2) 
 
445 (66.6) 
335 (66.9) 
34 (66.7) 
962 (71.4) 
287 (70.5) 
 
91 (13.6) 
68 (13.6) 
5 (9.8) 
174 (12.9) 
58 (14.3) 
Blood Glucose Status 
   Normal 
   Borderline 
   Diabetes 
 
2192 (74.7) 
408 (13.9) 
333 (11.4) 
 
68 (3.1) 
30 (7.4) 
19 (5.7) 
 
1479 (67.5) 
260 (63.7) 
183 (55.0) 
 
645 (29.4) 
118 (28.9) 
131 (39.3) 
 
2253 (75.7) 
409 (13.8) 
313 (10.5) 
 
375 (16.6) 
72 (17.6) 
69 (22.0) 
 
1604 (71.2) 
273 (66.8) 
186 (59.4) 
 
274 (12.2) 
64 (15.7) 
58 (18.5) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Continuous data presented as unadjusted mean (±SD) by sex and iron status 
Two sample T-test (*, **, *** denotes statistically significant differences between men and women by iron status) 
Significance set at 0.05 
Categorical data presented as N (%) by sex and iron status 
Suboptimal iron status defined as ≥2 of the following: ferritin level <15 µg/L, EPP >80 ug/dL, TS% <20, hb <12 for women 
and <13 for men. 
Elevated iron status defined as the following: TS% ≥50 or ferritin level ≥ 150 µg/L for women and ≥ 200 µg/L for men with 
CRP <10 mg/L or serum iron ≥ 155 µg/dL for women and ≥ 160 µg/dL for men. 
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 Telomere Length by Iron Status in Men (N = 2,933) 
 
Total Men 
N (%) 
Suboptimal 
Iron Status 
Sufficient 
Iron Status 
Elevated  
Iron Status 
Race 
     Non-Hispanic White  
     Non-Hispanic Black 
     Mexican/Hispanic  
     Multi-Racial    
 
5694.3 (5666.6, 5722.1) 
5855.5 (5800.8, 5910.3) 
5658.1 (5621.1, 5695.0) 
5725.2 (5579.4, 5871.0) 
 
5662.9 (5524.5, 5801.3) 
6161.2 (5892.9, 6429.4) 
5750.1 (5523.9, 5976.2) 
5917.2 (4382.3, 7452.1) 
 
5705.9 (5671.4, 5740.5) 
5866.3 (5795.8, 5936.7) 
5661.8 (5615.8, 5707.9) 
5744.0 (5538.0, 5950.0) 
 
5673.8 (5622.6, 5724.9) 
5789.9 (5684.6, 5889.3) 
5640.2 (5569.5, 5710.9) 
5672.8 (5315.0, 6030.7) 
 Telomere Length by Iron Status in Women (N = 2,975) 
 
Total Women 
N (%) 
Suboptimal 
Iron Status 
Sufficient 
Iron Status 
Elevated  
Iron Status 
Race 
     Non-Hispanic White  
     Non-Hispanic Black 
     Mexican/Hispanic  
     Multi-Racial    
 
5734.5 (5705.6, 5763.3) 
5943.5 (5888.9, 5998.2) 
5728.5 (5694.7, 5762.2) 
5796.7 (5675.5, 5617.9) 
 
5701.1 (5620.6, 5781.5) 
5973.0 (5854.2, 6091.8) 
5736.4 (5659.1, 5813.7) 
5776.5 (5238.0, 6315.0) 
 
5751.4 (5718.1, 5785.7) 
5918.7 (5846.1, 5991.3) 
5741.6 (5700.1, 5783.2) 
5804.0 (5604.4, 6003.5) 
 
5671.6 (5590.5, 5752.7) 
5991.7 (5844.8, 6138.6) 
5632.7 (5526.2, 5739.3) 
5785.1 (5357.6, 6212.7) 
Data presented as age-adjusted mean telomere length (95% CI) 
Suboptimal iron status defined as ≥2 of the following: ferritin level <15 ng/mL, EPP >80 ug/dL, TS% <20, hb <12 for women and <13 for men. 
Elevated iron status defined as the following: TS% ≥50 or ferritin level ≥ 150 ng/mL for women and ≥ 200 ng/mL for men with CRP <10 mg/L or serum iron ≥ 155 ug/dL for women and ≥ 160 ug/dL for men. 
† Log-transformed data 
 
Table 2.2: 
Age-adjusted mean telomere length by sex, ethnicity/race and iron status in eligible participants from the National Health and 
Nutrition Examination Survey (1999-2001). 
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 Model 11 Model 22 Model 3 3 
 β, (95%CI)4 p-value R-sq β, (95%CI)4 p-value R-sq β, (95%CI)4 p-value R-sq 
Iron Status 
     Sufficient 
     Suboptimal 
     Elevated  
 
-Ref- 
15.7 (-31.9, 63.2) 
-48.8 (-84.4, -13.2) 
 
--- 
0.518 
0.007 
0.171 
 
-Ref- 
-5.9 (-54.0, 42.3) 
-41.1 (-77.0, -5.2) 
 
--- 
0.812 
0.025 
0.185 
 
-Ref- 
2.5 (-45.7, 50.6) 
-36.7 (-72.6, -0.8) 
 
-- 
0.787 
0.045 
0.193 
Table 2.3: Multiple linear regression of iron status and telomere length in participants from the National Health and Nutrition Examination 
Survey (1999-2001) (N = 5,908). 
1 Adjusted for age 
2 Adjusted for age, gender and race/ethnicity 
3 Adjusted for age, gender, race/ethnicity, BMI†, education status, smoking status, and alcohol intake status 
4 Represents the change in mean telomere length per year 
Suboptimal iron status defined as ≥2 of the following: ferritin level <15 ng/mL, EPP >80 ug/dL, TS% <20, hb <12 for women and <13 for men. 
Elevated iron status defined as the following: TS% ≥50 or ferritin level ≥ 150 ng/mL for women and ≥ 200 ng/mL for men with CRP <10 mg/L or serum iron ≥ 155 ug/dL for women and ≥ 160 ug/dL for men. 
† Log-transformed data 
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